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INTRODUCTION
Reproductive rights should inform the next phase in HIV
prevention. Since the 1980s, medicine has made enormous strides in
preventing and treating HIV infections. Today, the Food and Drug
Administration (“FDA”) has approved forty different drugs to treat
HIV.1 In the last decade, AIDS-related deaths have fallen by more
than thirty percent.2 Still, new HIV infections predominately impact
young people.3 In particular, thirteen to twenty-four year olds
accounted for twenty-two percent of all new HIV-infections in 2014—
a number that has not significantly declined in the last decade.4 To
address these disparities among young people, the law should afford
minors the right to access HIV-prophylactic medication.
In 2012, the FDA approved Truvada—otherwise known as PreExposure Prophylaxis (“PrEP”)—to prevent HIV infections.5 PrEP
is a once daily pill composed of two antiretroviral drugs that reduce
one’s risk of HIV infection by ninety-two to ninety-nine percent.6
The World Health Organization (“WHO”), Centers for Disease
Control and Prevention (“CDC”), and United States Public Health
Service have all endorsed PrEP as an effective means to reduce the
risk of HIV infection.7 Expanding access to PrEP among thirteen to
twenty-four year olds could significantly reduce the persistent

1. See generally Antiretroviral Drugs Used in the Treatment of HIV Infection ,
U.S. FOOD & DRUG ADMIN. (Oct. 8, 2015), http://www.fda.gov/ForPatients/
Illness/HIVAIDS/Treatment/ucm118915.htm [https://perma.cc/VE24-LKNW].
2. See UNAIDS Reports a 52% Reduction in New HIV Infections Among
Children and a Combined 33% Reduction Among Adults and Children Since 2001 ,
UNAIDS (Sept. 23, 2013), http://www.unaids.org/en/resources/presscentre/
pressreleaseandstatementarchive/2013/september/20130923prunga
[https://perma.cc/B89N-3PXG].
3. See HIV Among Youth, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/hiv/group/age/youth/ [https://perma.cc/8U5K-CPEE].
4. See id.
5. See Treatment to Prevent HIV Infection (PrEP), AIDS INFONET (Oct. 22,
2016), http://aidsinfonet.org/fact_sheets/view/160 [https://perma.cc/Y8LH-DLAZ];
see also U.S. FOOD & DRUG ADMIN., supra note 1.
6. See Robert M. Grant et al., Preexposure Chemoprophylaxis for HIV
Prevention in Men Who Have Sex with Men, 363 NEW ENG. J. MED. 2587, 2597
(2010).
7. See discussion infra Section I.C.
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infection rate in this demographic—the demographic most at risk of
HIV infection.8
In New York State, however, a minor (a person under eighteen
years old) may consent to medical treatment only in unique
circumstances or for specified conditions, such as mental healthcare,
substance abuse treatment, or reproductive healthcare.9 Minors
generally do not have the capacity to consent to HIV treatment.10
PrEP, however, is a prophylactic medication.
It functionally
resembles birth control in its daily regimen and ability to prevent the
long-term health effects of sexual activity: pregnancy for birth control
and HIV for PrEP.11
Under New York law, a minor may pursue reproductive healthcare
without parental consent.12
Reproductive healthcare includes
accessing prophylactic medication, such as the birth control pill.13
New York should treat PrEP as another prophylactic medication vital
to reproductive health. As such, New York should recognize that,
under the U.S. Constitution and New York’s Public Health Law,
minors have a right to privacy that covers their right to access PrEP
without parental consent. New York can imbed PrEP within the
scope of reproductive healthcare through an Executive Order or
Department of Health (“DOH”) regulation. If the Executive Branch
refuses to act, this policy change should be pursued through litigation.
Through a reproductive rights analysis to a minor’s right to access
PrEP, New York can take important steps toward reducing the threat
of HIV infections, ending the AIDS epidemic,14 and preserving
individual autonomy in medical care.
This Article analyzes a minor’s capacity to consent to an HIV
prophylactic medication, PrEP, through a reproductive rights

8. See HIV Among Youth, supra note 3.
9. See discussion infra Section II.B.
10. See discussion infra Section II.A.
11. See Grant, supra note 6.
12. See discussion infra Section III.A.
13. See discussion infra Section III.A. The Guttmacher Institute has identified
the following as “contraceptive methods:” oral contraceptives (birth control or
morning after pill), injectable, male condom, natural family planning, vaginal ring,
patch, spermicide, IUD, copper IUD, hormonal IUD, diaphragm or cervical cap, and
sponge. See Jennifer J. Frost et al., Variation in Service Delivery Practices Among
Clinics Providing Publicly Funded Family Planning Services in 2010, GUTTMACHER
INST. 31 (2012), https://www.guttmacher.org/sites/default/files/report_pdf/clinicsurvey-2010.pdf [https://perma.cc/8BVH-Q29G].
14. See generally Ending the AIDS Epidemic in New York State, N.Y. ST. DEP’T
OF HEALTH
(Feb. 2016), https://www.health.ny.gov/diseases/aids/ending_the_
epidemic/ [https://perma.cc/VGE8-Q77N].
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framework. Part I discusses the history of HIV/AIDS as well as the
medical interventions available to treat the infection. It also describes
the emergence of prophylactic medication as the next stage in curbing
and, potentially, ending the HIV/AIDS epidemic. Part II outlines the
law governing a minor’s capacity to consent to medical treatment,
with a focus on HIV testing and treatment in New York State. Part
III discusses the reproductive rights of minors. In particular, Part III
recognizes that minors in New York have a right to access
contraceptive services without parental consent. Finally, Part IV
concludes that a minor’s capacity to consent to contraceptive services
is similar to the capacity to consent to HIV prophylactic medication.
Minors, therefore, should have a reproductive right to consent to
PrEP—an HIV prophylactic medication.
I. BACKGROUND: HIV/AIDS, TREATMENT, AND PREVENTION
While PrEP is a relatively new medical intervention, treatment and
prevention for HIV/AIDS has been available for several decades.15
This Section examines what HIV is, who it affects, and what
prevention and treatment options exist, as well as important and
necessary conditions to assess how PrEP can intervene in meaningful
and proactive ways.
A. What Is HIV?
HIV is the human immunodeficiency virus; infection with HIV
leads to a breakdown of the immune system, making the infected
person vulnerable to opportunistic infections, often resulting in
acquired immune deficiency syndrome (“AIDS”).16
HIV is
transmitted from an infected person to an uninfected person by
exposure to blood, semen, vaginal secretions, or breast milk.17 For
transmission to occur, fluid must come in contact with a mucous
membrane or damaged tissue or be directly injected into the
bloodstream.18 In the United States, HIV is most commonly
transmitted by anal or vaginal sex or by sharing needles with an

15. See generally History of HIV/AIDS Overview, AVERT, http://www.avert.org
/professionals/history-hiv-aids/overview [https://perma.cc/MDN2-H5R8].
16. See HIV Basics, CTRS. FOR DISEASE CONTROL & PREVENTION (Nov. 6, 2015),
http://www.cdc.gov/hiv/basics/ [https://perma.cc/QQ4L-MUWB]. See also infra notes
20-21.
17. See HIV Transmission, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec.
14, 2015), http://www.cdc.gov/hiv/basics/transmission.html [https://perma.cc/S7PZBD8X].
18. See id.
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infected person.19 The risk of transmission varies, depending on the
type of exposure; however, adherence to post-infection medication
and treatment can reduce the risk of further transmission by as much
as ninety-six percent.20
HIV causes damage by destroying blood cells that help the body
fight diseases, known as CD4+ or T cells.21 Some people develop
short-term symptoms within weeks of being infected with HIV, but
more often people do not experience significant symptoms for several
years.22 As the HIV virus spreads throughout the body, it destroys
CD4+ cells, which weakens the body’s immune system.23 Failure to
obtain early treatment for HIV may exacerbate underlying health
conditions, such as cardiovascular disease, kidney disease, liver
disease, and cancer.24 AIDS typically occurs in the late-stage of an
HIV infection25 when an infected individual’s immune system is
severely damaged and unable to fight certain diseases and cancers.26
Individuals with HIV/AIDS also face increased vulnerability to
certain categories of illnesses that attack weakened immune
systems.27
These illnesses, together known as “opportunistic
infections,” include tuberculosis, bacterial pneumonia, septicemia,
and lymphoma among others.28

19. See id.
20. See HIV Risk Behaviors, CTRS. FOR DISEASE CONTROL & PREVENTION (Nov.
16, 2015), http://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html [https://perma.cc/
A44V-83VE]. For example, exposure to HIV during a blood transfusion carries a
much higher risk of transmission than other exposures, such as oral sex.
21. See About HIV/AIDS, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec. 6,
2015), http://www.cdc.gov/hiv/basics/whatishiv.html [https://perma.cc/E3R7-97EY].
22. See id.
23. See id.; HIV Basics, supra note 16.
24. See About HIV/AIDS, supra note 21.
25. See id.
26. See id.
27. See HIV Related Opportunistic Infection: Prevention and Treatment,
AVERT (May 1, 2015), http://www.avert.org/hiv-opportunistic-infections.htm
[https://perma.cc/SCX9-M2EW].
28. See id. The stage to which the disease has progressed often dictates which of
these infections presents in an individual. For instance, individuals with HIV
experience higher rates of tuberculosis, malaria, bacterial pneumonia, herpes zoster,
staphylococcal skin infections and septicemia, while individuals with advanced HIV
or AIDS are more vulnerable to infections such as pneumocystus pneumonia,
toxoplasmosis and cryptococcosis. See id.
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B. The Demographics of HIV
There are more than 1.2 million people in the United States living
with HIV.29 As of 2013, approximately 129,000 people in New York
State were living with HIV or AIDS,30 nearly eighty percent of whom
live in New York City.31 In 2013, 3800 new individuals were
diagnosed with HIV in New York State,32 2832 of whom lived in New
York City.33 In 2014, the number of newly diagnosed individuals in
New York City dropped slightly to 2718.34 The New York City
Department of Health and Mental Hygiene (“DOHMH”) estimates
that one in five HIV-positive people do not know their status.35
Historically, gay, bisexual, and other men who have sex with men
(“MSM”) have been the individuals predominantly affected by
HIV/AIDS.36 This trend continues in New York State, with MSM
comprising approximately seventy-one percent of new HIV infections
in 2013.37 The plurality of these new MSM infections occurred in
people aged twenty-five to thirty-four (thirty-three percent or an
estimated 966 infections), while thirteen to twenty-four year olds
accounted for twenty-three percent of new infections.38 Thus, fifty-six
percent of new infections occur in those thirteen to thirty-four years
old. Although most age groups have seen a decline in new HIV
infections since 2006, the infection rate for thirteen to twenty-four
year olds has persisted, with the number of new infections in 2013
only slightly less than in 2006.39

29. See HIV in the United States: At a Glance, CTRS. FOR DISEASE CONTROL &
PREVENTION (Sept. 29, 2015), http://www.cdc.gov/hiv/statistics/overview/ata
glance.html [https://perma.cc/W3E9-4AEJ].
30. See HIV/AIDS: An Evolving Epidemic, N.Y.C. AIDS MEM’L (Jan. 2013),
http://nycaidsmemorial.org/resources/ [https://perma.cc/W2UE-SUV9].
31. See id.
32. See New York–2015 State Health Profile, CTRS. FOR DISEASE CONTROL &
PREVENTION (Dec. 2015), http://www.cdc.gov/nchhstp/stateprofiles/pdf/new_york_
profile.pdf [https://perma.cc/8P9T-398L].
33. See HIV Surveillance Annual Report, 2014, N.Y.C. DEP’T OF HEALTH &
MENTAL HYGIENE (Dec. 2015), https://www1.nyc.gov/assets/doh/downloads/pdf/
dires/2014-hiv-surveillance-annual-report.pdf [https://perma.cc/Z46H-5YXX].
34. See id.
35. See N.Y.C. AIDS MEM’L, supra note 30.
36. See HIV in the United States: At a Glance, supra note 29.
37. See HIV Incidence Estimates for New York State 2013, N.Y. ST. DEP’T OF
HEALTH (Dec. 2015), http://www.health.ny.gov/diseases/aids/general/statistics/docs/
hiv_incidence_2013.pdf [https://perma.cc/5NA2-TVFY].
38. See id.
39. See id.

2017]

THE OTHER PILL

731

It should be noted that HIV infection disproportionately affects
racial minorities.40 In 2013, African Americans and Latinos made up
only thirty-two percent of New York State’s population, but almost
seventy percent of estimated new HIV infections.41 At the end of
2012, there were approximately 496,500 African Americans living
with HIV in the U.S., forty-one percent of all Americans living with
the virus.42 In 2013, African Americans constituted fifty-four percent
of total deaths attributed to HIV/AIDS.43 The estimated HIV
infection rate for African Americans was six times higher than that of
whites, and the rate for Latinos was five times higher.44 Nationally,
the racial infection rate disparity is even greater. African American
and Latino MSM account for eighty percent of new infections of
MSM under the age of twenty-five, even though they typically engage
in less risky behavior than white MSM.45
C. HIV Treatment
In contrast to the first fifteen years of the HIV/AIDS epidemic,
there are now numerous treatment options available that suppress the
virus, allowing individuals to live symptom-free for longer periods.46
Combining these medications, referred to as HAART (Highly Active
Antiretroviral Therapy),47 limits or slows down the destruction of the
immune system and the development of AIDS, improves health, and

40. See id.
41. See id.
42. See HIV Among African Americans, CTRS. FOR DISEASE CONTROL &
PREVENTION (Feb. 4, 2016), http://www.cdc.gov/hiv/group/racialethnic/african
americans/ [https://perma.cc/L6FV-4F7T].
African Americans, however, only
comprise twelve percent of the U.S. population.
43. See id.
44. See N.Y. ST. DEP’T OF HEALTH, supra note 37.
45. Donald G. McNeil Jr., Poor Black and Hispanic Men Are the Face of H.I.V. ,
N.Y. TIMES (Dec. 4, 2013), http://www.nytimes.com/2013/12/05/us/poor-black-andhispanic-men-are-face-of-hiv.html [https://perma.cc/JS5R-776K]. While young Black
MSM have been shown to take fewer risks than their white peers (i.e., they had fewer
partners, engaged in fewer acts of sex while under the influence, and used condoms
more often), other risk factors, such as a lack of health insurance and the fact that
more of their partners were older black men (who are more likely to have untreated
HIV than older white men), may contribute to an explanation for this monumental
spike.
46. HIV/AIDS, NAT’L INST. OF ALLERGY & INFECTIOUS DISEASES,
http://www.niaid.nih.gov/topics/hivaids/understanding/treatment/pages/default.aspx
[https://perma.cc/UF7X-KW8F].
47. Marcie F. Rubin et al., Examination of Inequalities in HIV/AIDS Mortality in
the United States from a Fundamental Cause Perspective , 100 AM. J. PUB. HEALTH
1053 (2009) (defining HAART and explaining its effects on mortality).
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reduces the potential for transmitting the virus to others.48 Although
these treatments have transformed HIV/AIDS into more of a chronic
condition than the death sentence it once was, there remains no cure
for HIV or AIDS. In 2013 an estimated 12,963 people died from HIV
in the United States.49
The FDA has approved forty antiretroviral drugs (“ARVs”) for
HIV treatment.50 ARVs are organized into six major drug classes and
each group attacks HIV in a different manner.51
Medical
practitioners generally recommend that HIV-positive persons take
two or more ARVs from different groups at a time.52 Combining
ARVs significantly reduces the rate at which HIV becomes resistant
to the drugs, improving their efficacy.53
Although the “cocktail” of available treatments is a vast
improvement over previous medications, modern medications still
present difficulties, including potential side effects and unknown
harms that arise from long-term use.54 In light of the relative
uncertainty regarding the possible harms of long-term treatment,
medical experts only recently concluded that the benefits of starting

48.
49.
50.
51.

See About HIV/AIDS, supra note 21.
See HIV in the United States: At a Glance, supra note 29.
See U.S. FOOD & DRUG ADMIN., supra note 1.
Types of HIV/AIDS Antiretroviral Drugs, NAT’L INST.

OF ALLERGY &
INFECTIOUS DISEASES, https://www.niaid.nih.gov/diseases-conditions/types-hivaidsantiretroviral-drugs [https://perma.cc/B7Q5-3QZF] (last updated Sept. 23, 2013)
(explaining that the classes are entry inhibitors, fusion inhibitors, reverse
transcriptase inhibitors, integrase inhibitors, protease inhibitors, and multi-class
combination products; each class of drug attempts to interfere or interrupt the virus
cells from replicating or entering a patient’s own cells at a specific point during the
virus’ reproduction cycle).
52. Id. This approach is called “HAART.” See Rubin, supra note 47, at 1053.
53. Drug Resistance, AIDS.GOV, https://www.aids.gov/hiv-aids-basics/just-diagno
sed-with-hiv-aids/treatment-options/drug-resistance/ [https://perma.cc/X2V9-JQGN]
(last updated Apr. 20, 2016).
54. Long-Term Side Effects, AIDS.GOV, https://www.aids.gov/hiv-aids-basics/justdiagnosed-with-hiv-aids/treatment-options/side-effects/
[https://perma.cc/94PJRDT4] (last updated Aug. 7, 2009) (listing “Anemia (abnormality in red blood cells),
Diarrhea, Dizziness, Fatigue, Headaches, Nausea and vomiting, Pain and nerve
problems, Rash” as some of the short-term side effects of ARV treatments; also
listing lipodystrophy (a problem in the way the body uses and stores fat), insulin
resistance, lipid abnormalities, decrease in bone density, and lactic acidosis (a buildup
of cellular waste in the body)); see also David France, Another Kind of AIDS Crisis,
N.Y. MAG. (Nov. 1, 2009), http://nymag.com/health/features/61740/ [https://perma.cc/
7UJE-VQ9Y] (stating that “A striking number of HIV patients are living longer but
getting older faster—showing early signs of dementia and bone weakness usually
seen in the elderly.”).
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treatment early outweigh the risks.55 However, long-term health
concerns still exist.56 Beyond health concerns, there are also practical
and theoretical matters to consider. HIV treatment is complicated,
intensive, and costly.57
Though treatment has become less
burdensome and more effective over time, treatment regimens still
generally require taking various types of medication concurrently.58
Medications often have specific timing and dietary restrictions, with
which adherence is paramount.59 The strictures of treatment may be
especially daunting for an adolescent patient who must manage
medical appointments and treatment administration along with other
life demands. If an adolescent patient forgoes or avoids certain
components of treatment, the overall benefit of treatment may prove
ineffective.
Although there is potential for harm and the treatment regimens
are complex, treatment offers clear benefits, significantly reducing
morbidity and mortality regardless of age, race, sex, or method of
transmission.60 Moreover, treatment can reduce the risk of viral
transmission through sexual activity by up to ninety-six percent, a
significant public health consideration in the initiation of ARV
treatment.61 This discovery of reduced transmission rates has the
55. See Maggie Fox, Early Treatment Best for HIV, NBC NEWS (May 27, 2015),
http://www.nbcnews.com/health/health-news/early-treatment-best-hiv-study-confirms
-n365461 [https://perma.cc/TBN2-XRN5].
56. See Sean Cahill & Robert Valadéz, Growing Older with HIV/AIDS, 103 AM.
J. PUB. HEALTH e7 (2013) (“More research is needed to sort out the causality of
HIV/AIDS and HIV treatments in comorbidities, and the interactions of
antiretrovirals and other medications.”).
57. HIV Cost-Effectiveness, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/hiv/prevention/ongoing/costeffectiveness/ [https://perma.cc/9SCH
-RVM6] (last updated Sept. 23, 2013) (estimating the lifetime treatment cost of an
HIV infection at $379,668 in 2010 dollars). By contrast, HIV testing is noninvasive
and occurs quickly. See HIV Counseling & Testing Resource Directory, N.Y. ST.
DEP’T OF HEALTH, http://www.health.ny.gov/diseases/aids/providers/testing/docs/
testing_toolkit.pdf [https://perma.cc/B58T-3U23] (last updated June 2015).
58. HIV and Its Treatment, AIDS INFO, https://aidsinfo.nih.gov/educationmaterials/fact-sheets/21/51/hiv-treatment—the-basics#
[https://perma.cc/FCF7NHB4] (last updated Sept. 13 2016). However, more than one drug can be combined
into the same pill.
59. See generally Your Diet and Anti-HIV Drugs, AIDSMAP (Aug. 2016),
http://www.aidsmap.com/Your-diet-and-anti-HIV-drugs/page/2029328/
[https://perma.cc/K4SN-HJL2].
60. Palella, F. et. al., Declining Morbidity and Mortality Among Patients with
Advanced Human Immunodeficiency Virus Infection, 338 NEW ENG. J. MED. 853
(Mar. 26, 1998), http://www.nejm.org/doi/full/10.1056/NEJM199803263381301
[https://perma.cc/PU3M-MCQS].
61. Myron S. Cohen et al., Prevention of HIV-1 Infection With Early
Antiretroviral Therapy, 365 NEW ENG. J. MED. 493, 503 (2011).
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potential to significantly change the focus of HIV treatment and
prevention.
The use of ARV treatment for children and adolescents presents
some unique concerns. The market for pediatric ARV drugs is small
and there are few children to participate in clinical trials;62 as such,
most adult-approved drugs lack an FDA pediatric label indication.63
Thus, physicians often prescribe ARV treatment to minors without
always knowing the effective dosing.64 The federal Department of
Health and Human Services (“HHS”) cautions physicians to consult
with pediatric HIV specialists to identify patient and drug-specific
concerns and to investigate the availability of any clinical data on
each drug’s use in minors.65
D. PrEP
In 2014, the CDC issued guidelines endorsing a new mode of HIV
prevention.66 PrEP is a daily drug regimen, utilized as a prevention
strategy by individuals who do not have HIV, but who engage in
behavior that puts them at a higher risk of contracting it.67 PrEP
currently consists of one tablet of Truvada, a combination of two HIV
medications: tenofivir and emtricitabine.68 No health organization

62. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection ,
AIDSINFO, DEP’T OF HEALTH & HUM. SERVS., https://aidsinfo.nih.gov/guidelines/
html/2/pediatric-arv-guidelines/107/the-use-of-antiretroviral-agents-not-approvedfor-use-in-children [https://perma.cc/8H74-HZHC] (last updated Nov. 1, 2012).
Importantly, however, the use of ARV treatment by pregnant women living with
HIV can reduce the risk of HIV transmission to the child to below five percent
(whereas without treatment, the risk of transmission is between fifteen and forty-five
percent). See Prevention of Mother-to-Child Transmission (PMTCT) of HIV,
AVERT, http://www.avert.org/professionals/hiv-programming/prevention/preventionmother-child [https://perma.cc/QBS8-N29Y] (last updated Oct. 5, 2016).
63. See AIDSINFO, supra note 62.
64. See id.
65. See id.
66. See generally Preexposure Prophylaxis for the Prevention of HIV Infection in
the U.S., CTRS. FOR DISEASE CONTROL & PREVENTION (2014), http://www.cdc.gov/
hiv/pdf/prepguidelines2014.pdf [https://perma.cc/XC8U-9USC].
67. Pre-Exposure Prophylaxis (PrEP), AIDS.GOV, https://www.aids.gov/hiv-aidsbasics/prevention/reduce-your-risk/pre-exposure-prophylaxis/
[https://perma.cc/6QUH-VHYA] (last updated Jan. 29, 2016).
68. Id.; see also Guidelines for the Use of Antiretroviral Agents in HIV-1Infected Adults and Adolescents, DEP’T OF HEALTH & HUM. SERVS., https://aidsinfo.
nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf [https://perma.cc/24ARPKAL] (last updated July 14, 2016).
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recommends any other drug for the purposes of PrEP.69 The FDA
approved Truvada as PrEP for public consumption on July 16, 2012.70
Clinical studies have demonstrated that PrEP is highly effective at
reducing the risk of HIV transmission. A 2010 study (“the iPrEx
study”) compared Truvada with a placebo pill in nearly 2500 subjects,
consisting of MSM and transwomen in six countries.71 The study
demonstrated that for individuals with detectable levels of the drugs
in their blood (i.e., indicating that the medication was being taken
regularly), HIV transmission rates dropped by ninety-two percent.72
Further analyses indicated that daily adherence to PrEP may reduce
an individual’s likelihood of contracting HIV by ninety-nine
percent.73 In a study consisting of men and women in serodiscordant
couples, couples in which one partner had HIV but the other did
not,74 PrEP reduced the risk of HIV transmission by up to ninety

69. PrEP 101, BIRMINGHAM AIDS OUTREACH, http://www.birminghamaids
outreach.org/#!prep/c241g [https://perma.cc/N3CU-ZUFM] (“Although other HIV
drugs are currently being studied, no other pill besides Truvada . . . has been shown
to prevent HIV infection. Therefore, you should not use any other HIV pill in place
of Truvada.”).
70. FDA approves first drug for reducing the risk of sexually acquired HIV
infection, U.S. FOOD & DRUG ADMIN. (July 16, 2012), http://www.fda.gov/News
Events/Newsroom/PressAnnouncements/ucm312210.htm
[https://perma.cc/PQG5S2CA].
71. See Grant, supra note 6, at 2587-99 (studying Peru, Ecuador, South Africa,
Brazil, Thailand, and the United States).
72. See id.; see also AIDS INFONET, supra note 5 (noting that research showed
over ninety percent reduction in HIV infections when PrEP was taken four times a
week).
73. See AIDS INFONET, supra note 5. In a recent study, 100% of the participants
remained HIV-free during the 2.5 years of observation. The study was the first to
show results from a “demonstration project,” which examines medication use outside
the rigid confines of a placebo-controlled randomized controlled trial. This makes its
findings a somewhat better prediction of PrEP’s effects in a real-world setting. See
Jonathan E. Volk et al., No New HIV Infections with Increasing Use of HIV
Preexposure Prophylaxis in a Clinic Practice Setting, CLINICAL INFECTIOUS DISEASES
61, 1601-03 (2015); see also Benjamin Ryan, 100% Efficacy for Gays Who Adhered in
PrEP Study; Most Didn’t, POZ (July 22, 2014), https://www.poz.com/article/iPrExOLE-results-25922-2484 [https://perma.cc/2PHG-47VT]. However, in early 2016, one
patient, who used PrEP as directed, became infected with HIV, showing that while
Truvada may be especially effective, it does not eliminate the risk of contracting
HIV. See Trenton Straube, Meet the Man Who Got HIV While on Daily PrEP, POZ
(Mar.
3,
2016),
https://www.poz.com/article/meet-man-got-hiv-daily-prep
[https://perma.cc/9QQ3-UC2C].
74. A “serodiscordant” relationship is one in which one partner is HIV-positive
and the other is HIV-negative. See Raymond A. Smith, “Couples,” BODY (1998),
http://www.thebody.com/content/art14009.html [https://perma.cc/U35Z-F8YJ].
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percent.75 Among injection drug users, a daily tablet containing only
tenofivir reduced the risk of contracting HIV by nearly forty-nine
percent; for study participants who had detectable tenofivir in their
blood (i.e., regular use of the medication), it reduced the risk of
infection by seventy-four percent.76 Despite its efficacy, PrEP is
intended for use with condoms and clean needles, so that each
method can compensate for the deficits of the other.77 PrEP has no
reported major side effects, and minor side effects, such as nausea,
subside over time.78
Although Truvada was approved by the FDA for prevention
purposes in 2012, the CDC only amended its guidelines in May
2014.79 The guidelines recommend that individuals who are at “high
risk” for contracting HIV from sex or injection drug use consider
using PrEP to mitigate the risk of contracting the virus.80 Those at
“high risk” include any HIV-negative individual in an ongoing sexual
relationship with an HIV-positive partner; any HIV-negative gay or
bisexual man not in a mutually monogamous relationship who has
75. Jared M. Baeten et al., Antiretroviral Prophylaxis for HIV-1 Prevention
Among Heterosexual Men and Women, 367 NEW ENG. J. MED. 399, 405 (2012),

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770474/
[https://perma.cc/TP8MSE3F].
76. Kachit Choopanya, Antiretroviral Prophylaxis for HIV Infection in Injecting
Drug Users in Bangkok, Thailand, 381 LANCET 2083, 2088 (2013).
77. See HIV/AIDS: Pre-Exposure Prophylaxis (PrEP), CTRS. FOR DISEASE
CONTROL & PREVENTION, http://www.cdc.gov/hiv/risk/prep/index.html [https://perma
.cc/B8N7-MUZC] (last updated Sept. 19, 2016); see also Truvada: Important Safety
Information, GILEAD (2016), https://start.truvada.com/hcp/important-safety-infor
mation# [https://perma.cc/JG6E-Q89L]. A 2015 study demonstrated that MSM who
always use condoms and who adhere to the daily regimen of Truvada at a rate of at
least ninety percent have an estimated ninety-two percent lower HIV risk than those
who never use condoms or PrEP. In contrast, MSMs who only use condoms have a
seventy percent lower risk of an HIV infection. See Benjamin Ryan, How Well Do
Condoms and PrEP Prevent HIV Among Gay and Bi Men?, POZ (Feb. 4, 2015),
https://www.poz.com/article/condom-PrEP-efficacy-26766-8889
[https://perma.cc/9PBN-BTLY].
78. HIV/AIDS: PrEP, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec. 14,
2015), http://www.cdc.gov/hiv/basics/prep.html [https://perma.cc/J3Q4-F3JY]; see also
Mark Joseph Stern, There Is a Daily Pill That Prevents HIV. Gay Men Should Take
It, SLATE (Jan. 6, 2014), http://www.slate.com/blogs/outward/2014/01/06/truvada_
prep_hiv_gay_men_should_take_pre_exposure_prophylaxis.html
[https://perma.cc/2DT9-23KX] (stating that “Truvada has virtually no side effects”);
but see France, supra note 54 (outlining possible harms with long-term treatment).
79. See Preexposure Prophylaxis for the Prevention of HIV Infection in the U.S.,
supra note 66. As discussed, Truvada was an existing ARV drug, suitable for use as
treatment after infection, before being approved for PrEP. See DEP’T OF HEALTH &
HUM. SERVS., supra note 68.
80. See generally Preexposure Prophylaxis for the Prevention of HIV Infection in
the U.S., supra note 66, at 12.
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had anal sex without using a condom or has been diagnosed with a
sexually transmitted disease in the six months preceding PrEP
treatment; or any HIV-negative heterosexual man or woman who
does not regularly use condoms during sex with partners of unknown
HIV status.81 The CDC also recommends PrEP for HIV-negative
individuals who have injected drugs in the six months preceding PrEP
treatment and who have shared needles or been in drug treatment
during those same six months.82
A federal interagency working group led by the CDC developed
the 2014 Clinical Practice Guidelines; they reflect input from
stakeholders across the care spectrum, including providers, people
living with HIV, partners, and other affected communities.83 The
guidelines discuss whether PrEP is safe and effective for adolescents,
but conclude that current data is insufficient.84 The guidelines
recommend that states consider the benefits and risks of adolescent
use of PrEP in the context of local laws about autonomy in health
care decision-making by minors.85 However, while noting that past
HIV prevention methods have not been adequately successful, the
guidelines suggest that additional HIV prevention tools are necessary
to reduce the rate of new infections, “especially (but not exclusively)
among young adult and adolescent MSM of all races and
Hispanic/Latino
ethnicity
and
for
African
American
heterosexuals . . . .”86 Importantly, the guidelines note that while
parental or guardian involvement often may be desirable when
considering an adolescent minor’s use of PrEP, it may sometimes be
adverse to the safety of the adolescent.87
Since its introduction, PrEP has gained a lot of focus and attention,
both supporting and opposing its use. In July 2014, the WHO issued
guidelines strongly recommending MSM to consider taking PrEP as a

81. See id.
82. See id. at 30.
83. Guidelines and Recommendations, CTRS. FOR DISEASE CONTROL &
PREVENTION (Aug. 23, 2016), http://www.cdc.gov/hiv/guidelines/index.html
[https://perma.cc/5L6T-LE6Z].
84. See Preexposure Prophylaxis for the Prevention of HIV Infection in the U.S. ,
supra note 66, at 9, 43.
85. See id. at 42-43.
86. See id. at 13; see also McNeil, supra note 45 (explaining higher seroprevalence
and infection rates for young men of color).
87. Preexposure Prophylaxis for the Prevention of HIV Infection in the U.S. ,
supra note 66, at 42; see also discussion infra Section III.A.
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method of preventing HIV infection.88 New York Governor Andrew
Cuomo, as a part of his pledge to ends the HIV/AIDS epidemic in the
state by 2020, is committed to providing access to PrEP to high-risk
HIV-negative individuals to keep them from becoming infected with
HIV.89 Governor Cuomo has launched the PrEP Assistance Plan
(“PrEP-AP”), which reimburses service providers who treat eligible
individuals engaging in high-risk activity and seeking primary medical
care from experts in HIV prevention.90 PrEP-AP further ensures that
such individuals, if uninsured, receive PrEP through a manufacturerpatient assistance program.91
In his endorsement of PrEP, Governor Cuomo stated that
“expanding PrEP assistance is a critically important step toward
eradicating the AIDS epidemic in [New York] state.”92 His plan
recognizes that while New York has made strides in reducing HIV
infections for some individuals engaging in high-risk behavior,
including injection drug users, progress in reducing infection among
MSM, and particularly young MSM, has been slow.93 Medical experts
and advocates for persons with HIV have also endorsed the use of
PrEP as a safe and effective HIV prevention tool.94
PrEP, however, suffers from an image problem. PrEP’s most
vehement opponents come from within the HIV/AIDS activist
community.95 Many are concerned that once on PrEP, gay men will
88. Melissa Hellmann, WHO Says All Men Who Have Sex With Men Should
Take Antiretroviral Drugs, TIME (July 11, 2014), http://time.com/2975573/who-hiv-

aids-gay-men-homosexual-epidemic-rise/ [https://perma.cc/23LW-J2UM].
89. Pre-Exposure Prophylaxis Assistance Program (PrEP-AP), N.Y. ST. DEP’T OF
HEALTH,
https://www.health.ny.gov/diseases/aids/general/resources/adap/prep.htm
[https://perma.cc/749Z-X7WP].
90. Id.
91. Id.
92. Governor Cuomo Announces Program to Protect High-Risk Individuals from
HIV, PRESS OFF. OF GOVERNOR ANDREW CUOMO (May 12, 2015),
https://www.governor.ny.gov/news/governor-cuomo-announces-program-protecthigh-risk-individuals-hiv [https://perma.cc/WAN4-FP3Z].
93. Daniel Costa-Roberts, 8 Things You Didn’t Know About Truvada , PBS
NEWSHOUR (Apr. 12, 2015), http://www.pbs.org/newshour/rundown/8-things-didntknow-truvadaprep/ [https://perma.cc/W5VL-PDMN].
94. See, e.g., Stern, supra note 78 (“Basically Truvada is a miracle drug.”); see
also Alice Park, There’s a Drug That Prevents HIV. Let’s Use It, TIME (Nov. 16,
2015), http://time.com/4114402/aids-hiv-drug-prep/ [https://perma.cc/P7CF-J6LR]
(“And it’s time for more cities and states to take San Francisco’s lead and figure out
ways to make PrEP available to those who can benefit most.”).
95. Stern, supra note 78; see generally Tom Myers, HIV Prevention Pill Will Do
More Harm Than Good, U.S. NEWS (Aug. 3, 2012), http://www.usnews.com/
opinion/articles/2012/08/03/hiv-prevention-pill-will-do-more-harm-than-good-hiv-pillwill-give-a-false-sense-of-security [https://perma.cc/S3RA-6T98] (Myers, the author,
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stop using other precautions to reduce the transmission of HIV.96 In
fact, before the FDA approved Truvada, the AIDS Healthcare
Foundation lobbied the agency to reject the drug for use as PrEP.97
Regan Hofmann, the former editor-in-chief of Poz magazine has
derided PrEP as a “profit-driven sex toy for rich Westerners,”98 while
Dan Savage, a nationally syndicated sex columnist, has described
PrEP-users as “self-identified idiots who can only be saved by a
vaccine.”99 Critics have also expressed concern that HIV strains may
become resistant to PrEP, as well as the physiological harm that may
result from long-term use of Truvada.100
Several studies have demonstrated, however, that PrEP use does
not lead to “sexual risk compensation” (i.e., opting out of other safe
sex practices).101 Nonetheless, PrEP’s opponents have denigrated
individuals who have taken advantage of the medication, labeling
them “Truvada whores”102—individuals who take the drug to excuse
or justify their unsafe sexual behavior.103 PrEP’s advocates have since
reappropriated the term and have recast PrEP as “a drug that
represents the possibility of sexual autonomy and an opportunity to
push against the normative model” of heterosocialized queer life.104
is the chief of public affairs and general counsel for the AIDS Healthcare
Foundation).
96. Myers, supra note 95.
97. Id. The AIDS Healthcare Foundation is a Los Angeles-based non-profit
organization that provides medicine and advocacy to people with HIV/AIDS. It is
the largest provider of HIV/AIDS medical care in the United States. See AIDS
HEALTHCARE FOUND., http://www.aidshealth.org/#/about [https://perma.cc/99EX7XRS].
98. See Christopher Glazek, Why Is No One On the First Treatment to Prevent
H.I.V.?, NEW YORKER (Sept. 30, 2013), http://www.newyorker.com/tech/elements/
why-is-no-one-on-the-first-treatment-to-prevent-h-i-v
[https://perma.cc/4WWYSC9E].
99. Richard Morgan, Sex and the H.I.V. Morning-After Pill, N.Y. TIMES (June 28,
2013),
http://www.nytimes.com/2013/06/29/opinion/sex-and-the-hiv-morning-afterpill.html [https://perma.cc/2N7Y-F2BS].
100. See Myers, supra note 95.
101. See, e.g., Study Shows PrEP Does Not Lead to Increases in Risky Sex Among
Gay Men, CTR. FOR HIV IDENTIFICATION PREVENTION & TREATMENT SERVS. (Sept.
2013), http://chipts.ucla.edu/study-shows-prep-does-not-lead-to-increases-in-risky-sex
-among-gay-men/ [https://perma.cc/756S-PZL5].
102. See Park, supra note 94.
103. See Jim Burress, ‘Truvada Whores’ Stigma Endures Among Doctors and
LGBTS, ADVOCATE (Aug. 11, 2014), http://www.advocate.com/health/2014/08/11/tru
vada-whore-stigma-endures-among-doctors-and-lgbts [https://perma.cc/Z7TN-RN55].
104. See Aaron Braun, ‘Truvada Whores’ and the Class Divide, PACIFIC
STANDARD (Aug. 17, 2015), http://www.psmag.com/health-and-behavior/truvadawhores-and-the-aids-class-divide [https://perma.cc/7YED-X7VJ]. Though the author
does not use that term, by “heterosocialized queer life,” we refer to the experience of
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The social critics of PrEP raise valid concerns. Although PrEP
represents the next stage in the scientific study and medical treatment
of HIV/AIDS, science and medicine must coincide with social norms
and legal rules. The next Part of this Article addresses the legal rules
governing an individual’s access to PrEP.
II. ASSESSING THE CURRENT LEGAL LANDSCAPE
This Part outlines the laws governing a minor’s capacity to consent
to medical treatment, focusing on the capacity to consent to HIV
testing and treatment. In special circumstances a minor may be able
to consent to HIV testing and treatment, notwithstanding the typical
requirement of parental consent.
A. Informed Consent
Over a hundred years ago, writing for the New York Court of
Appeals in Schloendorff v. Society of New York Hospital, then-Judge
Benjamin Cardozo stated, “[e]very human being of adult years and
sound mind has a right to determine what shall be done with his
body . . . .”105
Throughout the past century, U.S. courts have
uniformly held that self-determination and individual autonomy are
the principles underlying the legal doctrine of informed consent—that
is, freedom from non-consensual interference with one’s person.106
Informed consent imposes two duties on medical providers: (1) the
duty to disclose information and (2) the duty to obtain informed
consent from the patient.107 The provider must disclose alternative
treatments as well as “reasonably foreseeable risks and benefits
involved as a reasonable medical, dental or podiatric practitioner

being a queer or LGBT-identified person in a world where heterosexuality is the
normal or preferred sexual orientation, and where, at least implicitly, queer or
LGBT-identified individuals are pressured to assimilate into such a model of
existence.
105. 211 N.Y. 125, 129 (1914) (holding that a surgeon who performs an operation
without patient consent commits an assault).
106. Paula Walter, The Doctrine of Informed Consent: To Inform or Not to
Inform?, 71 ST. JOHN’S L. REV. 543, 545-46 (1997) (citing Cruzan v. Mo. Dep’t of
Health, 497 U.S. 261, 269 (1990) (citing Union Pacific R.R. Co. v. Botsford, 141 U.S.
250, 251 (1891) (“No right is held more sacred, or is more carefully guarded, by the
common law, than the right of every individual to possession and control of his own
person from all restraint or interference of others, unless by clear and unquestionable
authority of law.”))).
107. See N.Y. PUB. HEALTH LAW § 2805-d (McKinney 2016); N.Y. MENTAL HYG.
LAW § 80.03(c) (McKinney 2011) (“Capacity to consent” requires that a person
understand his or her condition, the nature and purpose of the proposed and
alternative treatments, and the predictable risks and benefits of the proposed and
alternative treatments).
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under similar circumstances would have disclosed.”108 To grant
informed consent, the patient must (i) be competent, (ii) have the
capacity to consent, and (iii) voluntarily give consent, free from
coercion.109 Without all three elements, a person has not given
informed consent. And without informed consent, a medical provider
may not administer medical treatment absent an emergency.110
A patient may provide informed consent orally, in writing, or a
medical provider may infer consent through a patient’s conduct (“e.g.,
holding out an arm for a shot”).111 A medical provider’s failure to
obtain informed consent before treatment may result in liability for
medical malpractice.112
“Competency” is an essential element in the laws governing
informed consent and patient confidentiality.
Competency
encompasses the ability of a person to make decisions about her own
interests.113 If a person is not competent, then her decisions have no
legal effect.114 Adults are presumed competent unless adjudicated
“incompetent.”115 When the state determines that a person’s age or
disability interferes with her ability to make decisions for herself, the
state may invoke its parens patriae power to appoint a legal
guardian.116 The state has this power because it has a compelling
interest in providing care for citizens who are unable to care for
themselves.117
Minors are generally considered incompetent.118 Even though New
York law considers any person under eighteen years old to be a
minor, the law no longer sets a “blanket” age at which one becomes

108. N.Y. PUB. HEALTH LAW § 2805-d(1) (McKinney 2016). New York State uses
the “reasonable physician” standard, rather than the “reasonable patient” standard
that has been adopted by a majority of states.
109. See Bruce J. Winick, Competency to Consent to Treatment: The Distinction
Between Assent and Objection, 28 HOUS. L. REV. 15 (1991) (citations omitted).
110. See N.Y. PUB. HEALTH LAW § 2805-d(4)(c) (McKinney 2016).
111. See JESSICA FEIERMAN ET AL., N.Y. CIV. LIBERTIES UNION, TEENAGERS,
HEALTH CARE & THE LAW: A GUIDE TO THE LAW ON MINORS’ RIGHTS IN NEW
YORK STATE 12 (2001).
112. Section 2805-d, supra note 107.
113. Winick, supra note 109, at 16.
114. Id. at 22.
115. Id.
116. See Mills v. Rogers, 457 U.S. 291, 296 (1982).
117. Rivers v. Katz, 495 N.E.2d 337, 343 (1986) (citing Addington v. Texas, 441
U.S. 418, 426 (1979)).
118. See generally FED. R. CIV. P. 17(c)(2).
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“competent.”119 Courts determine a minor’s “competence” to
participate in discrete tasks, such as managing property, standing trial,
or consenting to medical treatment.120 For example, in New York, a
fourteen year old may be competent to testify as a witness,121 but
incompetent to consent to medical treatment.122 The next section
discusses a minor’s capacity to consent to medical treatment in New
York.
B. Minors’ Rights to Consent and the Confidentiality of Medical
Treatment in New York
New York law allows minors to consent to medical treatment and
receive confidential treatment from a licensed physician—in special
circumstances. Policy considerations, including the prevention and
treatment of HIV/AIDS, underlie these special circumstances. This
section outlines the provisions in New York’s legal code that allow a
minor to consent to and receive confidential medical treatment.

1.

Minors’ Capacity to Consent to Medical Treatment

New York law defines any person under eighteen years old as a
“minor.”123 In general, a minor lacks authority to consent to her own
medical treatment.124
Instead, medical providers must obtain
informed consent from an authorized person, such as a biological or
adoptive parent, legal guardian, or caregiver.125 “Parental consent”
laws are primarily motivated by the perception that minors are not
capable of making medical decisions on their own.126 Parents also
have their own rights, which include the right to custody, care, and

119. See N.Y. GEN. OBLIG. LAW § 1-202 (McKinney 2015); N.Y. C.P.L.R. 105(j)
(McKinney 2015).
120. Winick, supra note 109, at 23 (citing Katz, 495 N.E.2d at 341-43).
121. See Olshansky v. Prensky, 172 N.Y.S. 856 (N.Y. App. Div. 1918) (citing
People v. Linzey, 29 N.Y.S. 560 (N.Y. Sup. Ct. 1894)); 8 Carmody-Wait 2d § 56:16062.
122. N.Y. PUB. HEALTH LAW § 2504(1) (unless the person is the parent of a child
or has married).
123. See N.Y. GEN. OBLIG. LAW § 1-202 (McKinney 2015); N.Y. C.P.L.R. 105(j)
(McKinney 2015).
124. See Jennifer L. Rosato, What Are the Implications of Roper’s Dilemma for
Adolescent Health Law?, 20 J. OF L. & POL’Y 167, 174 (2011); Jennifer L. Rosato,

The Ultimate Test of Autonomy: Should Minors Have a Right to Make Decisions
Regarding Life-Sustaining Treatment?, 49 RUTGERS L. REV. 1, 18 (1996).
125. David M. Vukadinovich, Minors’ Rights to Consent to Treatment: Navigating
the Complexity of State Laws, 37 J. HEALTH L. 667, 672 (2004).
126. See Rosato, The Ultimate Test of Autonomy, supra note 124, at 18.
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control of their children.127 This affects the right of a minor to
consent to medical treatment because it typically falls within a
parent’s constitutional rights to maintain the health and well-being of
their child.128
New York’s Public Health Law, however, builds in two exceptions
to parental consent requirements. First, the “status” exception allows
a person under eighteen years old to consent to medical treatment if
she is a parent, married, serving in the military, or pregnant.129
Although pregnant minors may only consent to medical and dental
treatment related to their own prenatal care,130 upon giving birth, the
minor may consent to all forms of medical treatment for herself and
her child.131 In these circumstances, the law presumes that the minor
has the requisite capacity to consent to her own medical treatment.
Second, New York law recognizes a “treatment” exception for
minors who understand—as perceived by the medical provider—the
risk and benefits of reproductive healthcare,132 mental health
services,133 alcohol and drug abuse services,134 and sexual assault
treatment.135 They may consent to these treatments without parental
consent. Two rationales underlie this exception: (1) the recognition
of maturity among minors who seek certain treatments and (2) the

127. Id.; see also Wisconsin v. Yoder, 406 U.S. 205, 234 (1972) (recognizing that the
state cannot abrogate a parent’s right to raise their children, in particular the state
cannot compel parents to send their children under sixteen to formal high school);
Pierce v. Soc’y of Sisters, 268 U.S. 510, 534-35 (1925) (holding that a state cannot
violate due process rights of parents by requiring children attend public school);
Meyer v. Nebraska, 262 U.S. 390, 399-400 (1923) (holding that the Fourteenth
Amendment encompasses the right to bring up children).
128. See Rosato, The Ultimate Test of Autonomy, supra note 124, at 18 (citing
Lacey v. Lair, 139 N.E.2d 25, 30 (Ohio 1956)).
129. See generally N.Y. PUB. HEALTH LAW § 2504(1)-(4); N.Y. FAM. CT. ACT § 413
(McKinney 2016); see also Lowe v. Lowe, 888 N.Y.S.2d 163, 164 (N.Y. App. Div.
2009).
130. N.Y. PUB. HEALTH LAW § 2504(3) (pregnant minors may consent to “medical,
dental, health and hospital services relating to prenatal care”).
131. Id. at § 2504(1) (male parents also obtain this right upon becoming a parent).
132. Carey v. Population Servs., Int’l, 431 U.S. 678 (1977) (holding that the federal
right to privacy covers a minor’s decision affecting procreation); FEIERMAN ET AL.,
supra note 111, at 15. Reproductive healthcare includes family planning (i.e., birth
control and contraceptives), abortion, pregnancy and prenatal care, and care for
sexually transmitted infections (“STIs”). See also State Policies in Brief: Minors’
Access to STI Services, GUTTMACHER INST. (Nov. 2011), https://www.guttmacher.
org/state-policy/explore/minors-access-sti-services [https://perma.cc/7F23-4JEX].
133. N.Y. MENTAL HYG. LAW § 33.21 (McKinney 2011).
134. Id. at § 22.11.
135. FEIERMAN ET AL., supra note 111, at 15.
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barriers that “parental consent” may present to a minor obtaining
necessary medical treatment.
At a certain age, minors are “mature” enough to consent to certain
medical treatments despite their legal “incapacity.”136 “Mature
minors” are emotionally and intellectually mature enough to give
informed consent, and are recognized as a legal category by the
American Medical Association (“AMA”), American Academy of
Pediatrics (“AAP”), and by the highest courts of several states.137
Generally, when courts consider applying this exception to parental
consent requirements they weigh several factors, such as the minor’s
age, capabilities, experience, education, training, demeanor, and
judgment.138 If a minor is seeking medical treatment for reproductive
health, mental health, or drug and/or alcohol treatment, courts
typically conclude she has already demonstrated a requisite level of
maturity. Moreover, sexual activity and drug use are realities for
many “legal minors” and, similar to acute health conditions (e.g.,
reproductive health, mental health, and substance abuse), justify the
statutory exceptions to parental consent requirements.
New York courts, however, have not formally recognized the
category of “mature minors” who may obtain medical care without
parental consent.139 Although, in one case, the Queens County
Supreme Court applied the mature minor doctrine to determine
whether a seventeen year old could refuse blood transfusions on
religious grounds.140 Phillip Malcolm, seven weeks short of his
eighteenth birthday, required a blood transfusion, but both Mr.
Malcolm and his parents refused to consent to the transfusion
because of their beliefs as Jehovah’s Witnesses.141 In response, the
136. See Rosato, supra note 124, at 170-71 (collecting literature).
137. See, e.g., Opinion 5.055: Confidential Care for Minors, AM. MED. ASS’N J. OF
ETHICS (Nov. 2014); Policy Statement: Informed Consent, Parental Permission, and
Assent in Pediatric Practice, 95 PEDIATRICS 314, 315-16 (1995); Belcher v. Charleston
Area Med. Ctr., 422 S.E.2d 827, 837-38 (W. Va. 1992); In re E.G., 549 N.E.2d 322, 328
(Ill. 1989); Cardwell v. Bechtol, 724 S.W.2d 739, 745 (Tenn. 1987).
138. Dalizza D. Marques-Lopez, Note, Not So Gray Anymore: A Mature Minor’s
Capacity to Consent to Medical Treatment, U. OF HOUSTON L. CTR. (2006),
https://www.law.uh.edu/healthlaw/perspectives/2006/(DM)MatureMinor.pdf
[https://perma.cc/VLS8-XZY2].
139. FEIERMAN ET AL., supra note 111, at 23. New York also does not have a
statute that allows a minor to seek emancipation from her parents. That said, the
state has recognized minors as emancipated, so long as they live as if emancipated
(i.e., married, in the military, or economically independent). See FEIERMAN ET AL.,
supra note 111, at 20-21.
140. In re Long Island Jewish Med. Ctr., 557 N.Y.S.2d 239, 243 (N.Y. Sup. Ct.
1990).
141. Id. at 240.
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hospital petitioned the court to authorize its use of necessary medical
treatment, including blood transfusions.142 The court acknowledged
that courts in other states, including the Supreme Courts of Illinois
and Tennessee, have recognized the existence of the mature minor
doctrine143 and invited the New York legislature or appellate courts
to clarify its validity in New York State.144 Although the court found
merit in the “mature minor” doctrine, it refused to apply it to Phillip
Malcolm because, “his refusal to consent to blood transfusions is not
based upon a mature understanding of his own religious beliefs or of
the factual consequences to himself.”145
Despite the court’s
reluctance to formally recognize the “mature minor” doctrine as
applicable in New York, one may interpret Phillip Malcolm’s case to
mean that a mature minor standard does exist in New York State
because the court held it did not apply to his medical situation.146
Certain treatment exceptions to parental consent requirements also
exist because parental consent may create a “significant barrier” to a
minor accessing medical care.147 Requiring a minor to bring a
parent’s attention to her need for medical care related to sexually
transmitted infections (“STIs”), pregnancy, or drug use would create
volatility within the parent/child relationship.148 Minors would be
more likely to avoid family conflict at the expense of their health.149
In fact, one study found that when parental notice was mandated,

142. Id.
143. Id. at 243 (citing In re E.G., 549 N.E.2d 322 (Ill. 1989); Cardwell v. Bechtol,
724 S.W.2d 739 (Tenn. 1987)).
144. Long Island Jewish Med. Ctr., 557 N.Y.S.2d at 243 (recognizing that minors
may consent to outpatient mental health services, treatment for substance abuse and
sexually transmitted infections, and prenatal care or child care for minors with
children). The court also recognized New York’s statutory exceptions to the parental
consent law.
145. Id. (“It is recommended that the legislature or the appellate courts take a hard
look at the ‘mature minor’ doctrine and make it either statutory or decision law in
New York State.”). The court also recommended that the determination of whether
the minor is, in fact, a mature minor should first be established through a preliminary
hearing; only then should the substance of the matter be adjudicated. Id. at 243 n.16.
146. FEIERMAN ET AL., supra note 111, at 23.
147. Id. at 16.
148. OFF. OF TECH. ASSESSMENT, U.S. CONG., ADOLESCENT HEALTH-VOL. III:
CROSS-CUTTING ISSUES IN THE DELIVERY OF HEALTH AND RELATED SERVICES 134
(June
1991),
http://govinfo.library.unt.edu/ota/Ota_2/DATA/1991/9104.PDF
[https://perma.cc/25L3-KYHR].
149. See FEIERMAN ET AL., supra note 111, at 23.
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fewer than twenty percent of adolescents sought medical care for
STIs, pregnancies, or drug use.150
Medical providers recognize that facilitating access to confidential
care for STIs prevents harm to both the minor’s health and the public
health because STIs may be easily transmitted.151 Allowing minors to
consent to STI treatment enhances the speed of the treatment process
and helps contain a possible epidemic.152 Currently, preventing the
harms associated with foregoing mental health (or pre-natal care) and
substance abuse motivate the statutory exceptions to parental
consent. Mental health and substance abuse services are available to
minors because, when left untreated, both conditions may result in
harm to both the minor and others.153 Further, parental consent is
often not practical in treating a minor during periods of extreme
emotional distress or acute drug use.154 Access to confidential
medical services increases the likelihood that a minor seeks
treatment.155 Thus, the state’s prerogatives should align with medical
providers: quickly treating health conditions, containing possible
epidemics, and reducing public health harms, which override parental
barriers to consent and warrant the existing legal exceptions.

2.

Confidentiality of HIV Testing and Treatment

Medical providers have a duty to keep patient medical information
confidential.156
Disclosure without prior consent constitutes
professional misconduct.157 A minor’s right to confidentiality, just
like her right to give consent, may be circumscribed. When a parent
consents to medical treatment for a minor, information about the
treatment is generally disclosed to the parent.158 Only in the special
circumstances where a minor may consent to her own medical
treatment, a health care provider may withhold information about
that treatment to parents or other outside parties.159

150. Malizio Marks et al., Assessment of Health Needs and Willingness to Utilize
Health Care Resources of Adolescents in a Suburban Population , 102 J. PEDIATRICS

456, 459 (1983).
151. Vukadinovich, supra note 125, at 671.
152. Id. at 686.
153. Id. at 682-84.
154. Id. at 683-84.
155. Id. at 686.
156. 8 N.Y.C.R.R. § 29.1; 10 N.Y.C.R.R. § 405.7(c)(13); see also Griffiths v. Metro.
St. Ry. Co., 171 N.Y. 106, 111 (1st Dep’t 1902).
157. N.Y. EDUC. LAW §§ 6509(9), 6511; 8 N.Y.C.R.R. § 29.1(b)(8) (2011).
158. See FEIERMAN ET AL., supra note 111, at 25.
159. See id. at 26.
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There are two exceptions to disclosure when parents provide
consent for a minor’s medical treatment. First, a medical provider
must not disclose information that would be detrimental to the
provider-patient relationship or the parent-minor relationship.160 For
example, a provider treating a minor for substance abuse must not
disclose that medical information to a parent who is likely to disrupt
the minor’s course of treatment. Second, a medical provider may
withhold medical information if a minor objects to disclosure and is
twelve years old or older.161 In this context, disclosure is within the
provider’s discretion.
School health services also provide a general exception to
disclosure. The federal constitutional right of privacy protected by
the Fourteenth Amendment prevents the government and its agents
from disclosing a person’s private information.162 While parents
generally consent to school-based health services, an adolescent may
consent to medical care in school, and the school must keep that
medical information confidential.163 Federal law, however, only
ensures confidentiality for medical and treatment records maintained
by school health providers.164 Health records maintained by school
administrators, such as those related to enrollment in school (e.g.,
state-mandated vaccination records), are accessible to parents.165
Thus, to ensure confidential medical treatment of minors, school
health providers should keep confidential health information separate
from general health information related to education.166

a.

Testing and Confidentiality: Article 27-f

In the context of HIV prevention and treatment, concerns about
confidentiality and mandated disclosure may determine whether a
patient seeks medical care or advice in the first place. In 1989, New
York State enacted Article 27-f of the Public Health Law, addressing
testing, confidentiality, and disclosure of HIV-related information.167
160. N.Y. PUB. HEALTH LAW § 18(2)(c).
161. Id.
162. See Whalen v. Roe, 429 U.S. 589, 599 n.25 (1977); Sterling v. Minersville, 232
F.3d 190, 196-97 (3d Cir. 2000) (holding that disclosure of an individual’s sexual
orientation by a police officer violated the constitutional right to privacy).
163. See FEIERMAN ET AL., supra note 111, at 27.
164. See id. at 28.
165. See 20 U.S.C. § 1232(g) (2013) (denying funds to schools that refuse parents
access to student records).
166. FEIERMAN ET AL., supra note 111, at 28.
167. N.Y. PUB. HEALTH LAW §§ 2780-87 (McKinney 2015); see also Wendy A.
Barnhart, Note, Confidentiality of HIV and AIDS Related Information in New
York, 1 SYRACUSE J. LEGIS. & POL’Y 115, 115 (1995).
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Article 27-f mandates “maximum confidentiality”168 for HIV and
AIDS-related information to encourage voluntary testing and
treatment, and to protect individuals from diagnosis-based
discrimination.169
Article 27-f promotes a policy that seeks to reduce the social harms
(e.g., stigmatization, discrimination, etc.) associated with a diagnosis
or treatment.170 Any possible indication of an HIV infection results
in a range of discrimination against that person predicated on
“society’s accumulated myths and fears about disability and
disease.”171 Indeed, people with HIV experience discrimination in
employment, housing, and even dental and medical care unrelated to
HIV treatment.172 Discrimination has such a pervasive impact on
individuals, and on society, that many people forgo testing altogether.
For example, nearly forty percent of persons at risk of acquiring HIV
have not been tested.173 Concerns about privacy and discrimination
play a significant role in a person’s decision to receive an HIV test—
and if that person tests positive, concerns about privacy and
discrimination influence their decision to pursue treatment.
HIV testing is an essential precursor to treatment. New York
requires a person to give informed consent before an HIV test can be
administered.174 The law specifically requires medical providers to
provide information about HIV/AIDS and its treatment, disclose that
testing is voluntary and that HIV test results are confidential, and
inform the patient that the law prohibits discrimination based on HIV
status.175 The law also requires the person who communicates the test
results to counsel, or refer for counseling, the patient on the
emotional consequences of test results, discrimination, behavior

168. Human Immunodeficiency Virus and AIDS Related Information—
Confidentiality, 1988 N.Y. SESS. LAW SERV. 584 (McKinney) (“The legislature
recognizes that maximum confidentiality protection for information related to human
immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome
(AIDS) is an essential public health measure”).
169. Barnhart, supra note 167, at 115.
170. See Scott Burris, Law and the Social Risk of Health Care: Lessons from HIV
Testing, 61 ALB. L. REV. 831-32 (1998).
171. Id. at 831 (citing Sch. Bd. v. Arline, 480 U.S. 273, 284 (1987)).
172. Id. at 835; see also Hannah R. Fishman, HIV Confidentiality and Stigma: A
Way Forward, 16 U. PA. J. CONST. L. 199, 201 (2013).
173. Burris, supra note 170, at 833.
174. N.Y. PUB. HEALTH LAW § 2781(1) (2015). In 2014, the legislature amended
the law and deleted the “written or, where authorized by this subdivision, oral”
consent requirement. N.Y. Laws 2014, ch. 60 (Part A), § 2.
175. N.Y. PUB. HEALTH LAW § 2781(3)(a)-(g).
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change, medical treatment, and the need to notify contacts.176 New
York’s HIV informed consent law attempts to ensure that patients
understand the “full range of social risks and medical benefits to be
found in consenting to [the HIV test].”177 Through confidentiality
protections, it encourages testing and treatment.178
The statute, however, contains a contradiction in its treatment of
minors. Although Article 27-f authorizes minors to consent to HIV
testing without parental consent,179 it effectively prohibits minors
from receiving HIV-related treatment without parental consent.180
The statute defines “capacity to consent” as “an individual’s ability,
determined without regard to the individual’s age, to understand and
appreciate the nature and consequences of a proposed health care
service, treatment, or procedure . . . .”181 Thus, the statute defines
informed consent without regard to age. Nevertheless, the statute
contemplates disclosure to a minor’s parents by expressly authorizing
medical providers to disclose information to “a person authorized
pursuant to law to consent to health care for the individual.”182
Once a medical provider receives HIV-related information about
an individual, the provider must decide whether disclosure to anyone
other than the patient is “medically necessary in order to provide
timely care and treatment.”183 Because Article 27-f does not
explicitly provide minors with a right to consent to treatment, the
medical provider may determine that disclosure is “medically
necessary” if the minor requires HIV-related treatment, but refuses
to disclose her status to her parent or guardian. Before disclosing,
however, the medical provider must give the minor “appropriate

176. Id. § 2781(5); see also Elizabeth B. Cooper, Testing for Genetic Traits: The
Need for a New Legal Doctrine of Informed Consent, 58 MD. L. REV. 346, 396-97
(1999).
177. Cooper, supra note 176, at 397.
178. See generally Cooper, supra note 176, at 400.
179. N.Y. PUB. HEALTH LAW § 2781-(a)(1).
180. See LEGAL ACTION CTR., HIV/AIDS TESTING, CONFIDENTIALITY &
DISCRIMINATION: WHAT YOU NEED TO KNOW ABOUT NEW YORK LAW 9 (2nd ed.
2012) (stating that Public Health Law Article 27-f does not authorize a minor to
consent to HIV-related treatment); but see Wing Wah Ho et al., Complexities in HIV
Consent in Adolescents, 44 CLINICAL PEDIATRICS 473, 476 (2005) (stating that a
minor’s right to treatment is not clearly defined by the laws in New York, but
advocates argue that the basis for consent exists in law); see also Laura Gerace &
Max Colmers, Untitled Report on Article 27-f (2012) (on file with authors).
181. N.Y. PUB. HEALTH LAW § 2780(5) (emphasis added).
182. Id. at § 2782(1)(a); see also Gerace & Colmers, supra note 180.
183. N.Y. PUB. HEALTH LAW § 2782(4)(e)(1).
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counseling as to the need for such disclosure.”184 If the provider
determines that disclosure would not be in the minor’s “best interest,”
the law prohibits disclosure.185
As written, Article 27-f creates a treatment conundrum. The law
mandates that a medical provider arrange for medical treatment for
an HIV-positive individual—with that individual’s consent or
another’s consent as authorized by law.186 However, as discussed
above, disclosure of a minor’s HIV status may create volatility within
the parent-child relationship.187 Thus, medical providers confront the
statutory mandates for disclosure, but must also keep a minor’s “best
interests” in mind.188 Given this tension in the law, many providers
believe that minors should receive HIV treatment because
withholding treatment until consent is given by a parent might drive a
minor from care altogether.189

b.

Treating HIV As an STI So Minors May Consent Without
Parental Involvement

In New York, minors may consent to medical treatment related to
their reproductive health, mental health, or substance abuse.190
Reproductive healthcare is broadly defined and ranges from
providing birth control to treating STIs.191 If HIV were classified as
an STI, minors would be able to seek HIV-related treatment without
parental consent as part of their reproductive healthcare. There are
historical reasons, however, why this approach has not yet been
adopted.
In the 1990s, the DOH decided against classifying HIV and AIDS
as STIs as a means of furthering public health. By refusing to make
the classification, the DOH ensured that laws concerning reporting
and testing would not come into play.192 DOH’s classification took
184. Id. at § 2782(4)(e).
185. Id.
186. Id. at § 2781.
187. See discussion supra Section II.B.1.
188. See N.Y. PUB. HEALTH LAW § 2782(4)(e).
189. See Gerace & Colmers, supra note 180. (discussing interview with healthcare
provider and adolescent AIDS expert at New York area hospital in September 2011).
190. The right of minors to consent to reproductive healthcare without parental
involvement is derived from the federal right to privacy. See N.Y. MENTAL HYG.
LAW § 33.21 (right to consent to mental healthcare); N.Y. MENTAL HYG. LAW § 22.11
(right to consent to substance use or alcohol treatment); Carey v. Population Servs.
Int’l, 431 U.S. 678 (1977); see also FEIERMAN ET AL., supra note 111, at 15.
191. FEIERMAN ET AL., supra note 111, at 15.
192. N.Y. St. Soc’y of Surgeons v. Axelrod, 572 N.E.2d 605 (1991). Today, the risk
associated with driving the epidemic “further underground” has lessened. New York
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place early in the epidemic, before much of the currently available
treatment options, and reflected the concern among public health
experts that classifying HIV as an STI had the potential to exacerbate
the stigma attached to HIV infection and drive the epidemic further
underground.193
In response, the Society of Surgeons194 sued the DOH, alleging that
the agency’s Commissioner acted outside of the realm of his authority
in failing to classify HIV as a Sexually Transmitted Disease (“STD,”
i.e., STI).195 New York’s Court of Appeals disagreed.196 The court
applied the deferential standard of review to which state agencies are
entitled and held that determining which conditions should be
classified as STIs fell within the DOH’s discretionary powers and that
the Commissioner had not abused his discretion.197 But, in the last
year, Governor Cuomo has proposed amending the DOH’s
classification to facilitate youth access to HIV-related medication,
which could enable minors to more readily access PrEP.

c.

Governor Andrew Cuomo’s 2016 Proposal

In February 2016, New York Governor Andrew Cuomo proposed
new policies to change parental consent laws for HIV-positive teens
in need of treatment198 as part of a broader policy to end the AIDS
epidemic in New York by 2020.199 To combat HIV infections among

State allows public health officials to discuss partner notification with HIV infected
patients, prioritizing new diagnoses. Partners include spouses, sexual contacts, or
needle-sharing contacts. Patients are asked to voluntarily notify partners or provide
partner names for notification purposes. Partners are informed in person. See N.Y.
ST. DEP’T OF HEALTH, HIV Reporting and Partner Notification Questions and
Answers (2013), https://www.health.ny.gov/diseases/aids/providers/regulations/report
ing_and_notification/question_answer.htm#fiftyfive [https://perma.cc/FZS9-CCEJ].
193. Scott Burris, Driving the Epidemic Underground? A New Look at Law and
the Social Risk of HIV Testing, 12 AIDS & PUB. POL’Y J. 66 (1997).
194. The petitioner, New York State Society of Surgeons, consisted of four medical
societies that consist of New York State physicians. Axelrod, 572 N.E.2d at 606.
195. Sexually Transmitted Infections (“STIs”) more accurately describe medical
conditions that result from sexual activity. As opposed to Sexually Transmitted
Diseases (“STDs”), STIs encompass curable infections, which may not cause any
symptoms. STDs, on the other hand, alter typical bodily functions.
196. See generally Axelrod, 572 N.E.2d at 605.
197. Id. at 606.
198. GOVERNOR ANDREW M. CUOMO, BUILT TO LEAD: 2016 STATE OF THE STATE
257-59 (2016), https://www.governor.ny.gov/sites/governor.ny.gov/files/atoms/files/
2016_State_of_the_State_Book.pdf [https://perma.cc/UY7A-MFBS].
199. Jordyn Taylor, NY Gov. Cuomo Is Fighting the Laws Preventing Teens From
Getting Treatment for HIV, MIC (Jan. 21, 2016), http://mic.com/articles/133128/nygov-cuomo-is-fighting-the-laws-preventing-teens-from-getting-treatment-forhiv#.JxNZkcezd [https://perma.cc/DB44-ED5A]. Ending the epidemic would mean
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teenagers and expand access to treatment, the Governor proposed to
reclassify HIV as an STI, which would allow minors to consent to
treatment.200 Governor Cuomo’s proposal also sought to expand
access to HIV preventative services to all New Yorkers. If approved
by New York’s legislature, minors would be able to access PrEP
without parental consent under the reproductive health exception to
parental consent laws.201
Governor Cuomo’s proposal recognizes that expanding the means
for a minor to access PrEP is central to the “ending the epidemic”
campaign. New York has been recognized as a leader in the country
by advancing public health policies related to the prevention and
treatment of HIV. Most recently, New York also has been
recognized as a national leader in its effort to expand access to
PrEP.202 Since June 2014, PrEP use among Medicaid enrollees has
increased 400 percent.203 The Governor’s February 2016 policy
proposal converges with the policy proposal put forward by this
Article. But, as policymakers debate reclassifying HIV as an STI,
minors should still have access to PrEP without parental consent as a
reproductive right, guaranteeing privacy in receiving health services
related to reproductive healthcare.
III. BIRTH CONTROL
Reproductive rights are constitutional rights that protect both
adults and minors.
As Justice Blackmun wrote in Planned
reducing the number of new HIV infections to 750 or fewer each year. Id.; see also
N.Y. ST. DEP’T OF HEALTH, ENDING THE AIDS EPIDEMIC IN NEW YORK STATE
(2016), http://www.health.ny.gov/diseases/aids/ending_the_epidemic/ [https://perma.
cc/F4LB-45US]. In 2009, New York saw 4609 new HIV infections, but by 2013 that
number had been reduced to 3512. See BUREAU OF HIV/AIDS EPIDEMIOLOGY,
AIDS INST., N.Y. ST. DEP’T OF HEALTH, NEW YORK STATE HIV/AIDS
SURVEILLANCE ANNUAL REPORT: FOR CASES DIAGNOSED THROUGH DECEMBER
2013 (2015), http://www.health.ny.gov/diseases/aids/general/statistics/annual/2013/
2013-12_annual_surveillance_report.pdf [https://perma.cc/HP5A-LGQS]. New York
State has allocated $2.5 billion, with an additional $200 million from the executive
budget, toward combatting HIV/AIDS in the state. Governor Cuomo Announces
Next Phase of State’s Plan to End the AIDS Epidemic , PRESS OFF. OF GOVERNOR
ANDREW CUOMO (Nov. 30, 2015), https://www.governor.ny.gov/news/governorcuomo-announces-next-phase-states-plan-end-aids-epidemic [https://perma.cc/P7PPWSXV].
200. Governor Cuomo Announces Proposal Increasing Access to HIV Treatment
for Teens, PRESS OFF. OF GOVERNOR ANDREW CUOMO (Feb. 11, 2016),
https://www.governor.ny.gov/news/governor-cuomo-announces-proposal-increasingaccess-hiv-treatment-teens [https://perma.cc/LZX8-G673].
201. Id.
202. Id.
203. Id.

2017]

THE OTHER PILL

753

Parenthood of Central Missouri v. Danforth, “constitutional rights do

not mature and come into being magically only when one attains the
state-defined age of majority.”204 Reproductive rights exist within the
constitutional right to privacy. Both adults and minors share the
constitutional right to privacy.205 The right to privacy ensures
individual autonomy in rendering life-altering decisions, such as
whether to receive medical treatment, marry, or procreate (i.e.,
reproductive rights).206 Minors, therefore, have a right to privacy,
which manifests as patient-physician confidentiality in the medical
context.207
Although recent Supreme Court decisions have
provisionally limited the right to privacy,208 minors still have
reproductive rights that include access to confidential medical or
contraceptive services without the need for parental consent.209
This Part discusses the reproductive rights of minors by addressing
the key case law defining the framework of reproductive rights. It
concludes with a discussion of the law’s social impact, including a

204. 428 U.S. 52, 75 (1976).
205. See Griswold v. Connecticut, 381 U.S. 479, 484-86 (1965) (holding that a
statute prohibiting the use of contraceptives by married couples violated the
constitutional right to marital privacy); see also Planned Parenthood of Cent. Mo.,
428 U.S. at 74 (holding that the state may not impose a “blanket provision” requiring
parental consent for an abortion); Roe v. Wade, 410 U.S. 113 (1973) (recognizing that
the right to privacy covers, with some limitations, the decision to bear a child or
terminate a pregnancy).
206. Carey v. Population Servs. Int’l, 431 U.S. 678, 685 (1977) (collecting cases).
207. See GUTTMACHER INST., Minors’ Access to Contraceptive Services (Oct. 1,
2016), https://www.guttmacher.org/state-policy/explore/minors-access-contraceptiveservices [https://perma.cc/5LFP-PGCJ].
208. See, e.g., Webster v. Reprod. Health Servs., 492 U.S. 490 (1989) (upholding
Missouri law that forbade the use of public facilities for all abortions, except as
necessary to save a woman’s life, and required physicians to perform viability tests on
fetuses after twenty weeks of gestation); Hodgson v. Minnesota, 497 U.S. 417 (1990)
(holding that teens may obtain court authorization for an abortion instead of
complying with parental notification laws); Rust v. Sullivan, 500 U.S. 173 (1991)
(barring abortion counseling and referral by family planning programs funded under
Title X of the federal Public Health Service Act); Planned Parenthood of Se. Pa. v.
Casey, 505 U.S. 833, 877 (1992) (establishing the “undue burden test” that would
allow state regulation of abortion as long as it does not place a “substantial obstacle
in path of a woman seeking an abortion of a nonviable fetus”); Ayotte v. Planned
Parenthood of N. New Eng., 546 U.S. 320 (2006) (vacating and remanding New
Hampshire law requiring teens to wait forty-eight hours after parental notification for
an abortion because there was no medical emergency exception); Gonzales v.
Carhart, 550 U.S. 124 (2007) (upholding Partial-Birth Abortion Ban Act of 2003 and,
in the face of medical uncertainty, allowing lawmakers to overrule doctor’s medical
judgment to “promot[e] respect for human life at all stages in the pregnancy”).
209. See GUTTMACHER INST., Minors’ Access to Contraceptive Services, supra
note 207.
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reduction in teenage pregnancies and changes in popular attitudes
toward birth control.
A. Background: Minors’ Reproductive Rights
Reproductive healthcare is relevant to both minors and adults.
Nearly half (forty-six percent) of teenagers, between fifteen and
nineteen years old, are sexually active (i.e., have had sex at least
once).210 By age eighteen, most young Americans have had sex.211
Although parental involvement in a minor’s medical care often is
prudent, mandated parental involvement in a minor’s reproductive
healthcare could result in many minors forgoing treatment while
remaining sexually active.212
The law recognizes this social reality. Twenty-one states and the
District of Columbia allow minors to consent to obtaining
contraceptive services213 without the involvement of a parent or
guardian.214 Other states require unique circumstances to exist before
a minor, on her own, may access contraceptive services. These
exceptions include physician-determined necessity, marriage,
pregnancy or motherhood, or satisfying a “mature minor”
determination.215 Four states, however, have no explicit policy on a
minor’s capacity to consent to contraceptive services.216
210. American Teens’ Sexual and Reproductive Health, GUTTMACHER INST. (Sept.
2016), https://www.guttmacher.org/fact-sheet/american-teens-sexual-and-reproducti
ve-health [https://perma.cc/EQS9-2W58].
211. Id.
212. See GUTTMACHER INST., Minors’ Access to Contraceptive Services, supra
note 207.
213. The Guttmacher Institute has identified the following as “contraceptive
services:” oral contraceptives (birth control or morning after pill), injectable, male
condom, natural family planning, vaginal ring, patch, spermicide, IUD, copper IUD,
hormonal IUD, diaphragm or cervical cap, and sponge. See Jennifer J. Frost et al.,
supra note 13.
214. GUTTMACHER INST., Minors’ Access to Contraceptive Services, supra note
207. Those states include Alaska, Arizona, Arkansas, California, Colorado, Georgia,
Idaho, Iowa, Kentucky, Maryland, Massachusetts, Minnesota, Montana, New
Mexico, New York, North Carolina, Oregon, Tennessee, Virginia, Washington, and
Wyoming. Id. Access to abortion for minors is legally more complex. Most states
require parental consent or notification. Minors, however, have the constitutional
right to obtain a judicial bypass to parental consent requirements. See Hodgson v.
Minnesota, 497 U.S. 417 (1990). The policy goal of not deterring minors from
seeking health care often motivates policies that eliminate parental consent
requirements. See B. Jessie Hill, Medical Decision Making by and on Behalf of
Adolescents: Reconsidering First Principles, 15 J. HEALTH CARE L. & POL’Y 37, 4243 (2012).
215. GUTTMACHER INST., Minors’ Access to Contraceptive Services, supra note
207.
216. Id. Those states are North Dakota, Ohio, Rhode Island, and Wisconsin.
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The U.S. Supreme Court has recognized a constitutional right to
privacy for certain decisions that applies to both minors and adults.217
In 1965, Griswold v. Connecticut first recognized a constitutional
right to privacy in the penumbra of the First, Third, Fourth, Fifth, and
Ninth Amendments,218 holding that Connecticut could not restrict a
married couple’s access to birth control219 without intruding on the
constitutional right to marital privacy.220
Seven years later,
Eisenstadt v. Baird extended Griswold’s privacy protections by
invalidating a state statute that prohibited the sale of contraceptives
to unmarried couples.221 Eisenstadt found that the “goals of deterring
premarital sex and regulating the distribution of potentially harmful
articles” were insufficient state interests to justify the legislation.222
The constitutional right to privacy guarantees independence from
government interference in making important decisions about
marriage, procreation, contraception, and child rearing.223
In
particular, this right to privacy provides the foundation for a minor’s
right to obtain contraceptive services.224
When New York tried to regulate a minor’s access to contraceptive
services, the U.S. Supreme Court struck down the law. In Carey v.
Population Services, Int’l, the Supreme Court invalidated a provision
in New York’s Education Law that prohibited the advertising or sale
of non-prescription contraceptives to persons under sixteen years
old.225 The Court held that a law burdening the fundamental decision

217. See Planned Parenthood of Cent. Mo. v. Danforth, 428 U.S. 52, 74 (1976)
(holding that the state may not impose a “blanket provision” requiring parental
consent for an abortion); Griswold v. Connecticut, 381 U.S. 479, 484-85 (1965)
(holding that a statute prohibiting the use of contraceptives by married couples
violated the constitutional right to marital privacy); Roe v. Wade, 410 U.S. 113 (1973)
(recognizing that the right to privacy covers the decision to bear a child or terminate
a pregnancy).
218. 381 U.S. at 479.
219. Id. at 486.
220. Id.
221. 405 U.S. 438 (1972).
222. Id. at 443.
223. Carey v. Population Servs. Int’l, 431 U.S. 678, 684-85 (1977) (collecting cases).
“Child rearing” involves the custody, care, and control of a child, which has also
appeared in cases that address a parent’s decision on how to educate their child. See,
e.g., Wisconsin v. Yoder, 406 U.S. 205, 234-35 (1972) (recognizing that a state cannot
compel parents to send children to formal high school until age sixteen).
224. Carey, 431 U.S. at 694 (holding that blanket parental consent requirements on
contraceptive services were unconstitutional); see also Eisenstadt, 405 U.S. at 453-55
(holding that the prohibition of contraceptive services to single individuals, as
opposed to the married couples in Griswold, violates the Fourteenth Amendment).
225. 431 U.S. at 678.
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to “bear or beget a child . . . may be justified only by compelling state
interests, and must be narrowly drawn to express only those
interests.”226 However, a state restriction on the privacy rights of
minors is less rigorous, and only requires a “significant,” not
compelling, state interest because the state has “greater latitude to
regulate the conduct of children.”227 In Carey, the state’s goal of
deterring sexual activity among minors did not satisfy the
“significant” state interest standard.228 Absent a medical necessity to
prohibit the distribution of contraceptives to minors, a third party
veto—or
“blanket”
parental
consent
requirement—was
unconstitutional.229 Since Carey, New York State has not imposed
any restrictions on a minor’s right to access contraceptive services.230
Although Carey held that a state may not prohibit a minor from
accessing contraception absent a compelling state interest, the Court
did not address a minor’s right to access contraception when parents
or guardians disapprove.231 At least one court has implied that such a
right exists.232 In Arneth v. Gross, the Southern District of New York
held that a minor’s constitutional right to privacy includes the right to
use birth control.233
Additionally, through Medicaid and Title X, the federal
government funds clinics that make family planning services available

226. Id. at 686; see also Planned Parenthood of Se. Pa. v. Casey, 505 U.S. 833, at
859 (1992) (quoting Carey, 431 U.S. at 684-85).
227. Carey, 431 U.S. at 693 n.15 (citing Prince v. Massachusetts, 321 U.S. 158
(1944); Ginsberg v. New York, 390 U.S. 629 (1968)).
228. Carey, 431 U.S. at 701-02. In Casey, the Supreme Court invalidated
Pennsylvania’s Abortion Control Act, which required notification of a woman’s
spouse before undergoing an abortion. 505 U.S. at 895. Casey found that the spousal
notification requirement would likely prevent a significant number of women from
obtaining an abortion—that is, it constituted a “substantial obstacle.” Id. at 893-94.
The Abortion Control Act, therefore, placed an undue burden on a woman’s right to
reproductive healthcare. Id. at 895.
229. Carey, 431 U.S. at 693-94; but see Alfonso v. Fernandez, 606 N.Y.S.2d 259
(N.Y. App. Div. 1993) (holding that condom availability programs in public schools
must contain a parental opt-out provision). The implicit “parental consent”
requirement in Alfonso, however, cannot abrogate minors’ rights under the
Constitution. See FEIERMAN ET AL., supra note 111, at 38 n.87.
230. FEIERMAN ET AL., supra note 111, at 38.
231. B. Jessie Hill, Constituting Children’s Bodily Integrity, 64 DUKE L.J. 1295,
1307 (2015).
232. See, e.g., Arneth v. Gross, 699 F. Supp. 450, 452 (S.D.N.Y. 1988); see also
Brenda D. Hofman, Note, The Squeal Rule: Statutory Resolution and Constitutional
Implications – Burdening the Minor’s Right of Privacy, 1984 DUKE L. J. 1325, 1352
(1984).
233. Arneth, 699 F. Supp. at 452.
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to anyone regardless of age.234
These programs include
confidentiality safeguards for minors that enable clinics to provide
contraceptive or reproductive health services without involving
parents.235 If a minor seeks contraceptive services through a Title X
health provider, federal law requires that the provider must not
disclose the details of the minor’s care to their parents.236
Minors generally do not have a constitutional right to consent to
therapeutic or non-therapeutic medical interventions.237 In New
York State, reproductive healthcare—from birth control to STI
treatment—is an exception to parental consent laws.238 HIVprophylactic medication, such as PrEP, should fall within the existing
reproductive health exception.239 The state DOH—through executive
order or otherwise—can use a regulatory definition to place PrEP in
the current reproductive healthcare category. Strategic litigation is
also an option to move PrEP within the category of reproductive
healthcare.
Similar to birth control preventing pregnancies,
preventing HIV infections works against detrimental long-term health
consequences. As the next section discusses, the success of the birth
control pill is an important example.
B. Outcomes of Permitting Teen Access to Birth Control
The constitutional right to privacy protecting a person’s access to
contraceptive services has reduced teen pregnancies and provided
women with more control over their reproductive health. Between
1990 and 2008, the United States’ rate of teenage pregnancy dropped
by forty-two percent.240 For women aged fifteen to nineteen years

234. See 42 U.S.C. § 300, 1396; see also Heather Boonstra & Elizabeth Nash,
Minors and the Right to Consent to Health Care , GUTTMACHER INST. (2000),

http://www.guttmacher.org/pubs/tgr/03/4/gr030404.html
[https://perma.cc/Y4EC6W65].
235. See New York v. Heckler, 719 F.2d 1191, 1196 (2d Cir. 1983); Boonstra &
Nash, supra note 234.
236. See Boonstra & Nash, supra note 234.
237. Hill, supra note 231, at 1313.
238. See generally FEIERMAN ET AL., supra note 111, at 37-43.
239. Mental health services, drug treatment, STI treatment, and pre-natal care are
also exceptions to parental consent laws. Although analogously relevant to receiving
HIV treatment, this Article does not engage in an analysis of “treatment.” The
possibility for such an argument, however, should not be foreclosed. Instead, the
focus of this Article is on the “preventative” function of certain reproductive health
services. Birth control’s preventative or prophylactic function resembles PrEP in
practice and in law. See discussion infra Section IV.A.
240. See PLANNED PARENTHOOD, REDUCING TEENAGE PREGNANCY 4 (July 2013),
https://www.plannedparenthood.org/files/6813/9611/7632/Reducing_Teen_Pregnancy.
pdf [https://perma.cc/BP3K-4KK3].

758

FORDHAM URB. L.J.

[Vol. XLIV

old, this meant a decrease from 117 pregnancies per 1000 women to
67.8 per 1000.241 Additionally, between 1990 and 2008, use of the
birth control pill increased from nineteen to thirty-nine percent
among fifteen to seventeen year olds, and together with increased
condom usage, has been found responsible for a seventy-seven
percent decline in teenage pregnancies in that age group.242 Through
2002, the increased and better use of contraception among teens can
account for up to eighty-six percent of the decline in teenage
pregnancies.243
Beyond a reduction in the rate of teenage pregnancies, the advent
of the birth control pill has had far-reaching social consequences.
Despite initial concerns that the convenience of the pill would
promote promiscuity,244 the pill’s greatest impact has been social and
economic.
For example, birth control is one of the most
transformational developments in the business sector in the twentieth
century.245 One-third of the wage gains women have made since the
introduction of the pill in the 1960s have been the result of access to
this form of contraception.246 Absent access to the pill, one estimate
suggests the decrease in the gap between men and women’s annual
incomes “would have been 10 percent smaller in the 1980s and 30
percent smaller in the 1990s.”247 Early access to the pill (i.e., before
the age of twenty-one) is also a major factor that enables women to
pursue higher education.248 In 1970, college enrollment was twenty
percent higher among women who could access the pill legally by the
241. Id.
242. See id.
243. See id.
244. See Contraception:
Freedom from Fear, TIME (Apr. 7, 1967),
http://content.time.com/time/subscriber/article/0,33009,843551,00.html
[https://perma.cc/A4SQ-BZZD].
245. Kurt Soller, The Birth Control Pill Advanced Women’s Economic Freedom ,
BLOOMBERG BUSINESSWEEK (Dec. 4, 2014), http://www.businessweek.com/articles/
2014-12-04/birth-control-pill-advanced-womens-economic-freedom [https://perma.cc/
B53Q-B9NK].
246. Birth Control Has Expanded Opportunity for Women–In Economic
Advancement, Educational Attainment, and Health Outcomes, PLANNED
PARENTHOOD (June 2015), https://www.plannedparenthood.org/files/1614/3275/8659/
BC_factsheet_may2015_updated_1.pdf [https://perma.cc/4AW8-4XRM].
247. Id. at 1 (citing Adam Sonfield et al., The Social and Economic Benefits of
Women’s Ability To Determine Whether and When to Have Children ,
GUTTMACHER INST. (2013); Martha J. Bailey et al., The Opt-In Revolution?
Contraception and the Gender Gap in Wages, NBER Working Paper, No. 17922
(2012)).
248. See Adam Sonfield et al., The Social and Economic Benefits of Women’s
Ability to Determine Whether and When to Have Children , GUTTMACHER INST.
(2013).
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age of eighteen, compared with women who were barred from
accessing it by law before the age of twenty-one.249 Young women’s
legal access to the pill before the age of twenty-one also led to an
increase in women who graduated from college.250
The pill permitted young women to control their reproductive lives
and changed the balance of power between men and women in
American society, significantly furthering the pursuit of gender
equality and female autonomy.251 Generally, when individuals are
able to delay having children and can choose to have fewer of them,
“they tend to be more financially secure and better able to help their
children succeed.”252 The social and health-related benefits of
expanding access to the birth control pill are clear. Comparably,
expanding the definition of reproductive healthcare to include access
to HIV-preventative medication could effectuate similar social and
health-related outcomes among MSM thirteen to twenty-four year
olds, especially those living in communities of color.
IV. CREATING A PREP EXCEPTION IN NEW YORK STATE LAW
Access to PrEP should fall within the reproductive health
exception to a minor’s capacity to consent to medical care. Currently,
New York State classifies PrEP as HIV-related treatment. As such,
minors cannot readily access it without parental consent. Yet, PrEP
prevents HIV infections as effectively, if not more effectively, than
the pill prevents pregnancies. Although critics have expressed
concern about the side effects from long-term PrEP use, the potential
reduction in new HIV infections outweighs these concerns. This
section analyzes PrEP through a reproductive rights framework. It
also addresses and dispels the potential concerns with providing
minors access to PrEP.

249. See PLANNED PARENTHOOD, supra note 246, at 1 (citing Adam Sonfield et al.,
supra note 248; Martha J. Bailey et al., supra note 247).
250. See PLANNED PARENTHOOD, supra note 246; Elizabeth O. Ananat & Daniel
M. Hungerman, The Power of the Pill for the Next Generation: Oral Contraception’s
Effects on Fertility, Abortion, and Maternal and Child Characteristics, 94 REV. OF
ECON. & STAT. 37, 37-51 (2012).
251. Jaclyn Trop, 50 Years of Legal Birth Control: How it Changed the Workplace
for Women, FORTUNE (June 7, 2015), http://fortune.com/2015/06/07/50-years-legalbirth-control-workplace/ [https://perma.cc/UAB7-2QDX].
252. Max Nisen, The Long-Term, Extremely Positive Effects of Birth Control in
America, BUS. INSIDER (Oct. 7, 2013), http://www.businessinsider.com/positiveeffects-of-birth-control-2013-10 [https://perma.cc/58ML-PXL9].
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A. PrEP Functionally Resemble Birth Control
The primary similarity between the pill and PrEP is that they are
both preventative tools. Individuals use both to shield themselves
from adverse bodily consequences. New York’s current classification
of PrEP as HIV treatment, which precludes minors from accessing it,
is a misnomer. Even though Truvada is a combination of two existing
medications used to treat HIV, its separately approved use as PrEP
also makes the drug a prevention tool as opposed to a treatment
option.
This difference in function is an important one,
acknowledged by the New York State DOH.253
New York case law currently conflates treatment and prevention,
but does so in the context of classifying vaccinations.254 In practice,
the DOH distinguishes between treatment and prevention in the
context of minors’ access to STI treatment.255 The DOH recognizes
that preventative measures and treatment after an STI infection
occupy different positions on the continuum of care;256 as such, there
is no reason to exclude PrEP from this classification as prevention. In
classifying PrEP as HIV treatment, the DOH ignores its actual
function. It is also logically inconsistent with how New York treats
the prevention of STIs—as procedures distinct from treatment of
STIs.257
PrEP has numerous differences from HAART therapy (i.e.,
existing HIV treatment regimens). Apart from the clear functional
differences,258 Truvada as PrEP is one pill, taken alone; it has minimal
potential side effects, and requires less frequent monitoring by
medical professionals.259 Conversely, HAART is a combination of
numerous ARVs. HAART treatment requires routine blood testing
253. Legislative Memo: Regarding Expanding Access to STI Treatment and
Prevention for Minors, N.Y. CIV. LIBERTIES UNION (Apr. 13, 2015),
http://www.nyclu.org/content/regarding-expanding-access-sti-treatment-andprevention-minors [https://perma.cc/Y942-VREH] (outlining the disparity between
minors’ ability to access confidential treatment for STIs once infected and their
ability to access preventative care at the outset).
254. New York courts have recognized that when the term has been left undefined
by the legislature, the plain meaning of treatment encompasses comprehensive
preventive treatment. See, e.g., People v. Steinberg, 73 N.Y.S.2d 475, 477 (N.Y.C. Ct.
1947) (holding that “vaccination is a treatment given to a human being, even though
no disease is present” and the administration of a vaccine is “treatment as well as
preventive medicine.”).
255. See N.Y. CIV. LIBERTIES UNION, supra note 253.
256. See id.
257. See id.
258. See AIDS.GOV, supra note 53.
259. See supra text accompanying notes 68 and 78.
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to check viral load, CD4 counts, CD4/CD8 ratios, and a variety of
other factors. HAART treatment also requires more stringent
monitoring for general well-being, side effects, and other
complications. It involves more medications, more potential side
effects and drug interactions, and larger number of blood tests per
doctor’s visit than are needed for PrEP.260 Adherence to PrEP is
simpler than adherence to HAART therapy.261 Precluding minors
from accessing PrEP by maintaining its classification as HIV
treatment ignores the fact that taking a once-daily pill prevents HIV
infection.
In addition to the similarity as a mode of prevention, PrEP
resembles the birth control pill in other ways that weigh in favor of
similar legal treatment. PrEP and the pill are administered similarly;
each consists of a daily pill with a similar likelihood of preventing
respective adverse consequences (i.e., for PrEP it is an HIV infection,
whereas for birth control, it is unwanted pregnancy).262 PrEP and the
pill are both harm reduction strategies: the reality that minors will
engage in sexual activity, regardless of the risks, demands that the
state intervene to mitigate the public health risks involved. Finally,
both PrEP and the birth control pill rely on compliance with the daily
regimen for the full effect of the prevention therapy to work.263
Because PrEP is a prevention tactic, it should be distinguished
from the HIV treatment known as HAART therapy. Further, there
are clear and striking similarities between PrEP and the birth control
pill. Each is the functional equivalent of the other and the law should
treat the two prophylaxes similarly.
B. Minors Have a Right to Privacy That Covers Access to PrEP
Under New York law, minors may consent to medical care related
to their reproductive health without parental notification or
consent.264 Reproductive healthcare is an exception to parental
consent laws for two reasons: (1) a large portion of teenagers are

260. See generally Katie Peoples, Myth or Truth: Is There a Difference Between
PrEP and Treatment?, ADVOCATE (Oct. 8, 2014), http://www.advocate.com/31-daysprep/2014/10/08/myth-or-truth-there-difference-between-prep-and-treatment
[https://perma.cc/N2PN-76YJ].
261. See NAT’L INST. OF ALLERGY & INFECTIOUS DISEASES, supra note 51.
262. See supra text accompanying notes 67-68.
263. See supra text accompanying note 72.
264. See Carey v. Population Servs. Int’l, 431 U.S. 678, 694 (1977); see also
discussion supra Section II.B.2.b.
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sexually active265 and (2) parental notification or consent
requirements would deter minors from seeking reproductive
healthcare.266
Reproductive healthcare is a broad category. It includes services
related to birth control, prenatal care, treatment of STIs, and
abortions.267 This Article focuses on access to birth control as the key
reproductive health service. Because birth control falls within the
category of reproductive healthcare, minors have a right to access it
without parental interference.
As discussed in Section III.A, the constitutional right to privacy
covers medical treatment related to one’s reproductive health.268
Through the right to privacy, minors may access birth control without
parental consent, and generally, medical providers may not disclose
such information to parents.269 The constitutional right to privacy
should equally protect a minor’s right to access PrEP.
Confidentiality already protects medical information related to an
adult’s decision whether to receive an HIV-test or treatment.270
Article 27-f exemplifies the importance New York State places on the
confidentiality of HIV-related medical information.271
These
confidentiality provisions exist because medical information is always
sensitive, especially HIV-related information, due to social stigma
and discrimination.272
Additionally, in Carey, the Supreme Court recognized that a state
may not restrict a minor’s privacy rights unless such regulation would
serve a “significant state interest.”273 The right to privacy covers
access to contraceptives, which implicate the fundamental right,
265. See American Teens’ Sexual and Reproductive Health , GUTTMACHER INST.,
supra note 210; Laura Kann et al. Youth Behavior Risk Surveillance — United
States, 2013, 63 MORBIDITIY & MORTALITY WKLY. REP. 4, 24 (2013).
266. See Malizio Marks et al., Assessment of Health Needs and Willingness to
Utilize Health Care Resources of Adolescents in a Suburban Population , 102 J. OF

PEDIATRICS 456, 459 (1983) (noting that fewer than twenty percent of minors would
seek treatment for STIs, pregnancies, or drug use if parental consent was required).
267. See generally American Teens’ Sexual and Reproductive Health,
GUTTMACHER INST., supra note 210 (a leading organization in reproductive health
advocacy and policy research classing abortion, contraception, HIV and STIs, and
pregnancy (including pre-natal care) as categories of reproductive health).
268. See Carey, 431 U.S. at 684-85; see also Roe v. Wade, 410 U.S. 113, 152-53
(1973); Griswold v. Connecticut, 381 U.S. 479, 485 (1965).
269. See N.Y. PUB. HEALTH LAW § 18(2)(c) (McKinney 2010); see also Carey, 431
U.S. at 694; Arneth v. Gross, 699 F. Supp. 450, 452 (S.D.N.Y. 1988).
270. See discussion supra Section II.A.
271. See discussion supra Section II.B.2.a.
272. See Burris, supra note 170, at 831-32.
273. Carey, 431 U.S. at 693.
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shared by minors and adults, to autonomously make decisions that
impact their reproductive life.274 No “significant state interest” exists
to restrict a minor’s access to PrEP.275
Carey had previously declared that deterring sexual activity among
minors is an insufficient significant interest to preclude their access to
contraceptives.276 The same should be true for PrEP. No compelling
or significant medical reason exists for restricting a minor’s access to
PrEP. The FDA has approved PrEP for public consumption studies
on PrEP-related side effects are inconclusive or show minimal harms,
and PrEP may be the most efficacious method available to prevent
HIV-infection.277
If New York continues to impose barriers limiting a minor’s access
to PrEP, the current rates of HIV-infections among thirteen to
twenty-four year olds will likely continue.
If minors had a
reproductive right to access PrEP without parental consent, HIVinfection rates may fall precipitously, similar to the drop in teenage
pregnancies once states expanded minors’ access to birth control.278
C. Why the Arguments Against Expanding Access to PrEP Are
Wrong
This Article argues for an expansion of reproductive rights in order
to reduce the number of HIV-infections among minors in New York
State. Critics, however, may raise concerns that relate to existing
parental rights, adverse health outcomes, and medication compliance.
This Section addresses each concern in turn.
First, critics may invoke the legal rights currently afforded to
parents. In general, parents have the right to the care, custody, and
control of their children. Several Supreme Court decisions have
recognized that the Fourteenth Amendment encompasses a parent’s
right to raise their children as the parent chooses.279 In most cases, a

See id. at 684-85.
See id. at 693.
See id. at 695-96; see also Eisenstadt v. Baird, 405 U.S. 438, 443 (1972).
See AIDS INFONET supra note 5; Grant, supra note 6, at 2593; see also
Treatment to Prevent HIV Infection (PrEP), AIDS InfoNet, http://aidsinfonet.org/
274.
275.
276.
277.

fact_sheets/view/160 [https://perma.cc/25GR-PK24].
278. See John S. Santelli et al., Explaining Recent Declines in Adolescent

Pregnancy in the United States: The Contribution of Abstinence and Improved
Contraceptive Use, 97 AM. J. PUB. HEALTH 150, 154 (2007).
279. See Wisconsin v. Yoder, 406 U.S. 205, 213-14 (1972) (recognizing that state
cannot compel parents to send children to formal high school until age sixteen); see
also Pierce, 268 U.S. at 532 (holding that state cannot violate due process rights of
parents by requiring children attend public school); Meyer v. Nebraska, 262 U.S. 390,
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parent must consent before a minor receives medical care, which is
central to the care of a minor.280 Although care and custody
rationales also inform “parental consent” requirements, the Supreme
Court has tended to apply such parental rights in the educational
context.281
Minors’ access to PrEP, however, is different than the traditional
circumstances which would require parental consent. PrEP is a
medication designed for persons at risk of an HIV infection. Sexually
active teenagers are especially at risk.282 Further, many states
recognize a distinct category of “mature minors” who have the
cognitive ability to make decisions that affect their reproductive
health.283 Even without a legislative “mature minor” category, New
York State acknowledges the concept in reproductive decisionmaking.284 If a minor recognizes that risk, and takes appropriate
precautionary action in consultation with a medical provider, then a
minor demonstrates a level of maturity comparable to a person
eighteen years or older.285 By expanding access to PrEP, the law
would affirm the principles of autonomy that underlie informed
consent and encourage minors to pursue medical care—the same
goals underlying the state’s decision to permit minors to obtain
reproductive healthcare without parental consent.
Second, critics may assert that, as is often the case with new drugs
on the market, there are unanswered questions surrounding PrEP.
The long-term effects of taking Truvada as PrEP are currently
unknown. Ordinarily, Truvada has the potential to cause some
serious side effects, including lactic acidosis (i.e., build-up of digestive
acid), serious liver problems, or a greater likelihood of developing
399-400 (1923) (holding that the Fourteenth Amendment encompasses the right to
bring up children); Rosato, supra note 124, at 175.
280. See Rosato, supra note 124, at 174 (citing Belotti v. Baird, 443 U.S. 622
(1979)).
281. See id.; see also Pierce v. Soc’y of Sisters, 268 U.S. 510, 534-35 (1925).
282. See HIV Incidence Estimates for New York State 2013, N.Y. ST. DEP’T OF
HEALTH (Dec. 2015), http://www.health.ny.gov/diseases/aids/general/statistics/docs/
hiv_incidence_2013.pdf [https://perma.cc/3Z52-DGC3].
283. See, e.g., Am. Med. Ass’n, Confidential Care for Minors, 16 AM. MED. ASS’N
J. 901, 901 (2014); see also Am. Acad. of Pediatrics, Policy Statement: Informed
Consent, Parental Permission, and Assent in Pediatric Practice , 95 PEDIATRICS 314,
316 (1995); Belcher v. Charleston Area Med. Ctr., 422 S.E.2d 827, 833 (W. Va. 1992);
In re E.G., 549 N.E.2.d 322, 324 (Ill. 1989); Cardwell v. Bechtol, 724 S.W.2d 739, 746
(Tenn. 1987).
284. See N.Y. PUB. HEALTH LAW § 2504(1)-(4) (McKinney 2005).
285. See supra text accompanying notes 132–38 (noting that a minor who seeks
reproductive health, mental health, and substance abuse treatment demonstrates a
requisite level of maturity to overcome parental consent requirements).
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either of those.286 Tenofivir, one of the two drugs in Truvada, may
also lead to decreased bone density over time.287 The lack of answers,
or the potential negative health outcomes, may fuel PrEP’s critics,
especially when considering whether to permit a minor to access the
drug. Similar concerns were raised, and appropriately dispelled, for
the birth control pill.288 Although more potent when introduced, the
birth control pill became safer over time. Furthermore, the health
and social benefits in expanding access to the birth control pill for
teens outweighed the potential concern related to its side effects.289
PrEP is similar. PrEP’s potential to reduce the risk of HIV infection
significantly outweighs the costs of potential negative health
outcomes. And, as the medical community continues to research
PrEP, it will most likely become safer over time.
As an HIV prevention strategy, PrEP is unparalleled, surpassed in
efficacy only by sexual abstinence, which has proven an unreliable
public health strategy among teens.290 Concerns about health
consequences associated with long-term use should not impede
healthy individuals from preserving their health; this is especially true
for minors, who will remain sexually active—with or without PrEP as
a part of their daily regimen.
Third, another concern some may raise about minors obtaining
PrEP is that in order to be fully effective, it requires daily adherence,
which may be challenging. Similar arguments have emerged in the
context of taking the birth control pill on a daily basis. Education and
counseling services have bridged the gap in the birth control context,
and they can be similarly effective in the context of PrEP. Over time,
teens have come to understand that if they want to avoid pregnancies,
they need to maintain their daily regimen.291 A considerable
reduction in the number of teenage pregnancies supports this

286. See Important Safety Information, TRUVADA, http://www.truvada.com/
truvada-side-effects [https://perma.cc/9WRV-8CQQ].
287. See Grigsby et al., Tenofivir-associated bone density loss, 6 THERAPEUTICS &
CLINICAL RISK MGMT. 41, 42 (2010).
288. See Freedom from Fear, 89 TIME 100 (Apr. 7, 1967), http://content.time.com/
time/subscriber/article/0,33009,843551,00.html [https://perma.cc/2RW5-X8GH].
289. See discussion supra Section III.B.
290. See ADVOCATES FOR YOUTH, THE TRUTH ABOUT ABSTINENCE-ONLY
PROGRAMS (2007), http://www.advocatesforyouth.org/storage/advfy/documents/fsab
stinenceonly.pdf [https://perma.cc/N75C-DMJ8] (noting that abstinence only
education in eleven states may have negatively impacted youth’s willingness to use
contraception to prevent negative sexual health outcomes).
291. Claire Brindis & Laura Davis, Improving Contraceptive Access for Teens, 4
ADVOCATES FOR YOUTH 1, 3 (1998) (noting that in recent years, teen contraceptive
use and compliance has increased).
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understanding. Currently, PrEP is relatively unknown to the groups
that may most require it. An increase in education and awareness will
likely be as effective as promoting daily adherence to PrEP as it was
for the birth control pill.292
Additionally, the CDC estimates that the cost of lifetime treatment
of an HIV infection is $379,668.293 PrEP has been shown to be very
cost-effective in studies conducted outside of the United States,
cementing itself as an important public health strategy for the
prevention of HIV transmission among individuals of all ages.294
The legal and medical communities should embrace the expansion
of access to PrEP to minors. Doing so will help reduce HIV
infections and save lives. But, more significantly, it makes sense from
a legal and policy perspective.
CONCLUSION
PrEP’s introduction to the market has been an important milestone
in the fight against HIV/AIDS. PrEP has reinvigorated the hope that
the end of the epidemic is in sight. Governor Andrew Cuomo’s
administration has endorsed and outlined a plan to expand access to
PrEP to minors by reclassifying HIV as an STI. Another viable
approach is to include PrEP within the reproductive health exception
to parental consent through a DOH regulation or affirmative
litigation. PrEP and the birth control pill are functionally similar:
both are a once daily pill that ensure a person’s reproductive health.
The law must recognize this similarity and codify access to PrEP as a
matter of reproductive health, ensuring that minors have the ability to
access PrEP to protect themselves against HIV. By applying a
reproductive rights analysis in this context, New York will be one step
closer towards ending the AIDS epidemic and preserving individual
autonomy in medical care.

292. See id. at 5.
293. See HIV Cost-effectiveness, CTRS. FOR DISEASE CONTROL & PREVENTION
(2015), http://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.
html [https://perma.cc/N9M9-4XB9] (calculating the cost of HIV treatment in 2010
U.S. dollars).
294. See, e.g., Estelle Ouellet et al., Cost effectiveness of ‘on demand HIV pre-

exposure prophylaxis for non-injection drug-using men who have sex with men in
Canada, 26 CAN. J. OF INFECTIOUS DISEASES & MED. MICROBIOLOGY 1, 23 (2015)

(finding that the average annual total cost of one HIV infection ranged from $27,410
to $35,358, while the annual cost of PrEP was $12,001 per participant, and the amount
per life saved was roughly $621,390 per infection prevention.).

